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ABSTRACT 
The project focused on the isolation, characterization and synthesis of secondary 
metabolites of Gunnera perpensa L. (Gunneraceae), a South African medicinal plant used 
by many South African women to induce or augment labour and as an antenatal medication 
to tone the uterus. From the methanol extracts of the rhizomes we have isolated the 
compounds Z-venusol, methyl lespedezate, 4-6>-/?-D-glucopyranosyl-3,3',4'-tri-0-
methylellagic acid and punicallagin. Structural elucidation of the compounds was 
performed using NMR spectroscopy. The presence of ellagic acid derivatives and 
hydrolysable tannins have not previously been reported from the family Gunneraceae. 
The study also focuses on the development of an HPLC analytical method to fingerprint 
the crude extracts of G perpensa. This method was used to determine the chemical 
composition of the rhizomes of the G. perpensa collected in different parts of South Africa. 
It is clear from the HPLC study that the rhizomes contain large concentrations of the 
hydrolysable tannin punicalagin and the second most abundant metabolite was Z-venusol. 
However, it was observed from plants collected in different regions that the ratio between 
punicalagin and Z-venusol differs substantially in the different extracts. 
An ellagic acid derivative isolated from G. perpensa contains a biaryl structure derived 
from gallic acid. The synthesis described in this thesis focused on reaction methods to 
access unsymmetrical biaryls and two synthetic routes were investigated - one that relies 
on the Ullmann reaction and the second that uses the Heck coupling reaction. Success of 
this coupling reaction towards the formation of ellagic acid derivatives was accomplished 
by the Heck coupling reaction method. One of the most important considerations towards 
the synthesis was the manipulation of hydroxyl groups of gallic acid by selective 
protection reactions that provide entry to the aforementioned preparation of unsymmetrical 
ellagic acid derivatives. 
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1.1 BIOACTIVE NATURAL PRODUCTS 
The journey of natural product chemists began in the 19th century when they took up the 
challenge of determining the structures of complicated natural products. Encouraged by a 
society who values many natural products for their life-giving properties, chemists have 
applied their skills and intellect to many tens of thousands of molecules made by living 
organisms. By the 20th century natural products began to attract the attention of the 
biological disciplines such as clinical biochemistry, pharmacology, toxicology, 
microbiology and cell biology. The discovery of antibiotics gave the study of natural 
products a great boost and ensured that natural products remained central to growing 
pharmaceutical companies. 
Plants have formed the basis of sophisticated traditional medicine systems that have been 
in existence for thousands of years.1 The use of plants in traditional medicine of many 
cultures has been extensively documented. The first records, written on hundreds of clay 
tablets in cuneiform, are from Mesopotamia and date from about 2600 BC. Amongst the 
approximately 1000 plant-derived substances which they used were oils ofCedrus species 
(cedar) and Cupressus sempevirens (cypress), Glycyrrhiza glabra (licorice), Commiphora 
species (myrrh), and Papaver somniferum (poppy juice), all of which are still used today 
for the treatment of ailments, ranging from coughs and colds to parasitic infections and 
inflammation. 
Chinese medicine has been documented extensively with the first record dating from about 
110 BC. The Indian Ayurvedic [Ayus (r), meaning life, and Veda meaning knowledge] 
system dates to about 1000 BC and it takes a holistic view of man, his health and illness.2'3 
Plant-based systems continue to play an essential role in health care, and it has been 
estimated by the World Health Organisation that approximately 80% of Africa's 
inhabitants rely mainly on traditional medicines for their primary health care. At least 119 
chemical substances derived from 90 plant species can be considered as important 
prescription drugs that are used by one or more countries. Of these 119 drugs, 74% were 
discovered as a result of chemical studies directed at the isolation of active substances from 
plants used in traditional medicines.5 
Clinical, pharmacological and chemical studies of traditional medicines derived from 
plants led to early drugs such as aspirin (1.1), digitoxin (1.2), morphine (1.3), quinine (1.4) 
and pilocarpine (1.5). The discovery of antibacterial penicillin by Fleming in 1928 and 
subsequent re-isolation and clinical studies by Chain, Florey and co-workers in the early 
1940s, and the commercialization of synthetic penicillin revolutionized drug discovery 
research. 
Analysis of Ayuverdic remedies resulted in discovery of the drug reserpine (1.6), 
occasionally prescribed for hypertension, from the root of the climbing shrub Rauwolfia 
7 8 9 
serpentina. ' ' Some important chemotherapeutic agents currently in use for the treatment 
of certain types of cancers are plant based. Vinblastine (1.7) and vincristine (1.8) both 
isolated from Catharanthus roseus, are used for the treatment of Hodgkin's disease, 
lymphosarcoma and leukaemia.10'11 Irenotecan (1.9), first isolated from the Chinese tree 
Camptotheca acuminata but now obtained mostly from the Indian tree Nothapodytes 
2 
12,13 nimmoniana, is used for the treatment of lung, ovarian and cervical cancers. ' Taxol 

















O C6H5 O 
HO = H 6Ac 
OBz 
1.10 
Southern Africa has a rich botanical diversity with approximately 24 000 species in this 
region. Of these, about 4 000 plant species are used in traditional medicine to remedy 
different diseases. The chemistry and pharmacology of many of these medicinal plants 
have not been investigated yet. South Africa can benefit from the scientific evaluation of 
this indigenous knowledge base. 
Recently, P59 (1.11), a compound with appetite suppressant activity, was isolated from the 
South African plants Hoodia pilifera and H. gordonii (Apocynaceae: Asclepiadaceae).1415 
Obesity is increasingly associated with health problems and a natural appetite suppressant 
may play an important role in future. However, despite the success story of Hoodia, there 
are many other local medicinal plants that need to be investigated. 
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1.2 AIM OF THE STUDY 
The only South African Gunnera species is Gunnera perpensa L. known as uGobho in 
isiZulu and river pumpkin in English. G. perpensa rhizomes are used by many South 
African women to induce labour and as an antenatal medication to tone the uterus. South 
African indigenous people have also used it to treat other illnesses like rheumatic fever, 
swellings, menstrual pain and stomach bleeding. Preliminary screening of the crude 
extract of this plant for uterotonic effects have been reported.16 However, prior to this 
investigation, no information was available on the phytochemistry of this plant. 
The aims of the current study are: 
• The isolation and characterisation of the secondary metabolites in the rhizome of G. 
perpensa 
• The development of analytical methods to determine chemical markers present in G. 
perpensa 
• The investigation of chemical variation of plants collected in different geographical 
regions 
• The synthesis of an ellagic acid derivative and related compounds isolated from the 
rhizomes. 
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PLANTS WITH UTEROACTIVITY (OXYTOCIC PLANTS) 
2.1 INTRODUCTION 
The use of traditional herbal medicines related to pregnancy has been documented throughout 
the world. Indigenous people in different parts of the world have and still are using decoctions 
made from plants to facilitate labour in childbirth. The chemical properties and/or the 
potential toxicity of the plants known to be used during pregnancy have been explored and in 
some plants the active chemical constituent is known. Plants that produce uterine contraction 
have similar action to that of the hormone oxytocin. 
Oxytocin is the principal uterine-contracting and milk ejecting hormone of the posterior 
pituitary produced in the hypothalamus. It is released in pulses into the circulation systems to 
the targeted sites during child labour. In 1909, Sir Henry Dale discovered and described the 
uterine contractile effect of oxytocin and after analysis came to the conclusion that oxytocin 
came from the pituitary gland. In 1954 V. du Vigneaud described oxytocin as a polypeptide. 
Many studies showed that the use of oxytocin may help to optimize delivery without 
disastrous effects.3 In 1992, a nocturnal peak in the concentrations of plasma oxytocin was 
found to correlate with the nocturnal peak in the uterine activity in late pregnancy. Oxytocin 
acts on the uterine myometrial cells that are responsible for contraction of the uterus and is 
therefore important in medical control of labour in modern obstetrics. One should not lose 
sight of the risks associated with mother or fetus with induction i.e. fetal distress, uterine 
dysfunction and hyperstimulation. By careful use of oxytocins, these risks can be reduced and 
to avoid adverse effects while using oxytocin, the correct dose is important.4'5 The first drugs 
to be used for their uterotonic activity were ergot alkaloids, followed by oxytocin and later 
prostaglandins. 
6 
2.2 SOUTH AFRICAN OXYTOCIC PLANTS 
A review compiled by Steenkamp6 revealed that one hundred and fifty-six plant species 
distributed in seventy-three plant families are used by indigenous people of South Africa to 
treat gynaecological problems. The majority of these plants are used to treat infertility (ninety 
species). Plants are also used to treat menstrual disorders: amenorrhoea (fifteen species), 
dysmenorrhoea (forty-four species), menorrhagia (twenty-nine species) and irregular 
menstruation (four species). Many of the plants are prepared as decoctions and taken orally. 
In the Vhavenda tribe, the plant part is burnt and the smoke directed into either the vagina 
[Barleria randii (Acanthaceae)] or the vulva [Tabernaemontana elegans (Apocynaceae), 
Acokanthera oppositifolia (Apocynaceae), Asparagus buchananii (Asparagaceae), Capparis 
tomentosa (Capparaceae), Maerua cafra (Capparaceae), Berchemia discolor (Rhamnaceae), 
Osyris lanceolata (Santalaceae)]. For the treatment of amenorrhoea, powdered plant material 
is applied to underwear as in the case of Albizia brevifolia Schinz (Fabaceae), Brackenridgea 
zanguebarica (Ochnaceae) and Pterocarpus angolensis (Fabaceae).7 
o 
Veale et al. has identified fifty-seven plant species that are used by South African traditional 
people during pregnancy and childbirth, and important plants in this respect are: Clivia 
miniata (Amaryllidaceae), Asclepias fruticosa (Asclepiadaceae), Callilepis laureola and 
Vernonia tigna (Asteraceae), Gunnera perpensa (Haloragaceae), Gladiolus sericeovillosus 
(Iridaceae), Bowiea volubilis (Hyacinthaceae), Eulophia clavicornis and Eulophia tenella 
(Orchidaceae), Pentanisia prunelloides (Rubiaceae), Grewia occidentalis (Tiliaceae), Typha 
capensis (Typhaceae) and Rhoicissus tridentate (Vitaceae). 
Decoctions of Agapanthus africanus and C. miniata of South Africa have been reported to 
have uterotonic activity on the isolated uterus preparation. Since the uterus comprises of 
myometrial and an endometrial layer, their mode of action towards different oxytocins could 
be different. Veale et al9 compared the mode of action of two plant extracts on a stripped 
myometrium preparation to acetylcholine and atropine. Both extracts inhibited uterotonic 
7 
activity in the myometrium to acetylcholine. Atropine inhibited response of the myometrium 
only to the A. africanus extracts. 
Preliminary studies by Kaido et al.10 of plants used in South Africa as herbal remedies 
investigated the activity of the crude decoction of each plant on the isolated rat and ileum 
preparation. The oxytocic plants investigated by the authors were A. africanus, P. 
prunelloides and G. perpensa. Their results showed that aqueous extracts of all three plants 
initiated contractions in the isolated rat uterus and that the G perpensa extract showed no 
response on the rat ileum. 
Veale et al. ' has investigated the effects of the extract of A. africanus (Agapanthaceae) on the 
isolated rat uterus. The plant is used by South African women as a decoction (in isihlambezo) 
during pregnancy and also in inembe, a decoction used to induce labour. It was also revealed 
that Agapanthus was one of the five plants used to treat complication associated with child 
labour. Preliminary studies reported that the extract of the leaves induces the initial response 
of the uterus to oxytocin. Compounds isolated from the plant includes yuccagenin (2.1), 
sapogenin agapanthagenin (2.2), 7-dehydroagapanthagenin (2.3), 8(14)-
dehydroagapanthagenin (2.4), and 9(1 l)-dehydroagapanthagenin (2.5).I2'13 
8 
Sewram et alu has reported a fast, safe and sensitive method for determining the uterotonic 
activity of medicinal plants. The South African plants used to evaluate and validate the 
method were C. miniata, Ekebergia capensis, Grewia accidentalis and Asclepias fruticosa. 
These plants were chosen for their current use by some black South African women to either 
to aid the fetus growth or to act as uterotonic agents to facilitate labour. The extract of C. 
miniata, A. fruticosa and E. capensis showed maximum uterotonic activity and the extract of 
G. occidentalis only induced uterine muscle contraction. Compounds isolated from the 
hexane extract of seeds of E. capensis tree are limonides: capensolactones (2.6 to 2.11) and 
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In the supercritical fluid extract of E. capensis, five compounds were isolated by Sewram et 
1 n 
al. and the uterotonic effects of each was determine. These compounds were identified as (3-
sitosterol (2.13), oleanolic acid (2.14), 3-e/?/-oleanolic acid (2.15), 2,3,22,23-tetrahydroxy-
2,6,10,15,19,23-hexamethyl-6,10,14,18-tetra-cosatetraene (2.16) and 7-hydroxy-6-
9 
methoxycoumarin (2.17). The two compounds oleanolic acid and 3-epz'-oleanolic acid 












Supercritical fluid extraction of the roots of C. miniata resulted in the isolation of two 
uteroactive compounds. The active compounds that were found to individually induce muscle 
contractions were identified to be linoleic acid (2.18) and 5-hydroxymethyl-2-
furancarboxaldehyde (2.19). The mode of action of compound 2.19 was assessed with the use 







The presence of alkaloids in the roots and leaves of C. miniata were reported. The isolated 
alkaloids are Oacetyl-(9-a-(hydroxyefhyl)lycorine (2.20)19, clivonidine (2.21)20, cliviahaksine 
(2.22)21, and two antiviral agents clivimine (2.23) and lycorenan-7-one (2.24)22 but none of 
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2.3 NON-SOUTH AFRICAN OXYTOCIC PLANTS 
The two Mexican plants Montanoa tomentosa and M. frutenscene (Heliantheae) are commonly 
known as 'zoapatle' and have been used since ancient times for their oxytocic properties. 
From the active extract, a putative oxytocic fraction was isolated as a complex mixture. In the 
mixture four oxepane diterpenoids, zoapatanol (2.25), montanol (2.26), tomexanthin (2.27), 
tomentol (2.28) and a sesquiterpene lactone, tomexanthol (2.29) were identified. Of all the 
compounds isolated in the uterotonic-active mixture, zoapatanol (2.25) and tomentol (2.28) 
were as active as the component mixture 23 
11 
Monechma ciliatum (Acanthaceae) is traditionally used in the Plateau State of Nigeria to 
induce labour. The hot methanolic extract of the plant was found to have potent oxytocic and 
oestrogenic activities.24 A lignan, lariciresinol dimethyl ether, has been isolated from M. 
ciliatum}^ However, bioassay-guided fractionation indicated that the oxytocic principle is 
very polar and the putative active compound was identified as a small peptide made up of 
tyrosine, leucine and a third component which is probably serine.26 
Oldenlandia affinis (Rubiaciae) is a medicinal plant of the northern Congo and south-western 
Central African Republic. The decoction of the plant is used in Central African Republic to 
facilitate labour. People of Congo use an aqueous decoction called 'Kalata-Kalata' as a native 
drug during labour and the source plant was discovered to be O. affinis. The earliest report on 
the uteroactive effect of the plant dates back to 1965 by Sandburg.27 When the decoction of O. 
affinis was tested on the oestrogenised rat uteri, it showed a very strong uterine activity.28 
Based on those reports and observations Gran et al. isolated and identified a uteroactive 
cyclic peptide, kalata-Bl (Fig 2.1), which consists of 29 amino acids. 
12 





valyl-L-cysteinyl-L- threonyl),cyclic(7-*21 ),(11 -+23),(16-»28)-tris(disulfide). 
Another medicinal plant used in tropical parts of Africa for its oxytocic activity is Musanga 
cecropioides (Cecropiaceae). The tree is found in the tropical forest of Africa from Guinea to 
Congo and is used by indigenous people to induce labour. The uterotonic effect of the leaf on 
the rat uterus was reported by Kamanyi et a/.31 and recently the uterotonic effect of the water 
extract of the stem bark was reported by Ayinde et al. Phytochemical studies of the leaf, 
stem bark and the root wood had been reported.33'34 Compounds isolated from the plant are 
triterpenes: methyl musancropate A and B (2.30 and 2.31), methyl cecropiacic (2.32), methyl 
musangate A (2.33), methyl musangate B (2.34), methyl euscaphate A and B (2.35 and 2.36) 
and musangicic acid (2.37). 
13 
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2.36 R>= OH, R2= H 
2.37 R'=H, R2=Me 
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2.32 R'= R2= H 
2.33 R'= H, R2= OH 
2.34R ]=OH, R2=H 
Aspilia mossambicensis, a medicinal plant used by chimpanzees contains two uteroactive 
diterpenes. In Tanzania the leaves of the plant are consumed by chimpanzees in an unusual 
manner for self medication. It has been observed that young leaves of this plant are consumed 
more often by female chimpanzees than males. In East and West Africa A. mossambicensis is 
used by women to alleviate menstrual cramps and to treat pregnancy-related complications. 
Driven by its use by human beings and the consumption behavior by chimpamzees, the 
authors decided to investigate the bioactive constituents of dried plant leaves. The bioassay-
guided fractionation led to the isolation of two diterpenes, kaurenoic acid (2.38) and 
grandiflorenic acid (2.39). Both these compounds exhibited uterostimulatory activity. These 
compounds have also been isolated as the active constituents of Montanoa tomentosa, a 




Some plants used in the Dominican Republic to treat women's conditions such as uterine 
fibroids, menorrhagia, endometriosis and hot flushes have been reviewed. The bark and 
roots of Gossypium barbedense (Malvaceae) are used to treat uterine hermorrhaging and to 
regulate menses. The leaves of Lippa micromera (Verbenaceae) are used to regulate menses. 
A plant considered to be a woman's plant Matricaria chamomilla (Asteraceae) is used to treat 
uterine colic. Two frequently reported plants in the Republic are Per sea americana 
(Lauraceae) and Momordica charantia (Cucurbitaceae). P. americana was classified by 
Browner as a plant for uterine expulsion and retention and is also used for menorrhagia as it is 
claimed to stop bleeding. P. americana (avocado leaves) contain flavonoids; apigenin 
(2.40), luteolin (2.41), luteolin 7-O-glucoside (2.45), astragalin (2.46) and two glycosylated 
38,39 abscisic acids (2.48 and 2.49). ' Phytochemical studies on the flowers of M. chamomilla 
revealed they contain the flavonoid apigenins (2.40), luteolin (2.41) and the glycosides 2.42 -
2.45. 40 
R J 0 ^ 
R2O^T-JUCU 
OH 
OH O OH O 
2.40 R= H 
2.41 R= OH 
2.42 R= R'= Rz= R3= R4= H 
2.43 R= R!= R2= R4= H, R3= Ac 
2.44 R= R'= Ac, R2= R3= R4= H 
2.45 R= R'= R2= R3= R4= OH 
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Bourdy et al. looked at the oestrogenic activity of five plants reported to be used as 
traditional medicines in Vanuati. The young fronds of Aspelenium nidius (Aspleniaceae) are 
used as a contraceptive and to reverse sterility. The leaves of Dysoxylum gaudichaudianum 
(Meliaceae) are used as an early abortifacient. A decoction of leaves of Hemigraphis reptants 
(Acanthaceae) are claimed to reverse sterility and the fruits of Homalanthus nutans 
(Euphorbiaceae) are used as an abortifacient and the infusion of the bark of Pemphis acidula 
(Lythraceae) is used as an abortifacient. All five plants tested showed no significant activity. 
In rural western Uganda it has been reported that 80% of pregnant women give birth at home 
and are helped by traditional birth attendants. Herbal medicines are used by birth attendants to 
induce labour, remove the retained placenta and for the management of post-partum bleeding. 
Seventy-five medicinal plant species of Uganda and one fungus species were reported as being 
used to induce labour during child birth. The documented plant species include the herbal 
drug Cleome gynandra (Capparidaceae) which is used to hasten child birth, the seeds of Luffa 
cylindrical (Cucurbitaceae) and an infusion of the leaves from Vernonia amygdalina which are 
used as abortifacients and the dried and fresh leaves of Erlangia cordifolia which are used to 
induce labour. 42,43 
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Adhatoda vasica L. Nees is a well-known medicinal plant in Ayuverdic and Unani medicine. 
It has been used in the indigenous system of medicine in India for more than 2000 years. It 
has also been used to treat various diseases, specifically respiratory tract ailments. Recent 
reports on the use of the plant in connection with child labour have appeared. Jain et alAA 
observed that the Neterhat people in Bihar used a decoction of leaves to stimulate and heal 
before and after delivery. It was also observed that people in the Gora village of Lucknow, 
Utta Pradesh use A. vasica as an abortificient.45 Phytochemical studies on the plant revealed 
the presence of several alkaloids, steroids and alkanes.46 The major biologically active 
compound found in leaves, roots and flowers of the plant is an alkaloid vasicine (2.50). 
Vasicine is a compound that was reported to possess uterine-stimulating activity with a similar 
effect to oxytocin.47 Other alkaloids isolated from the leaves includes vasinone (2.51), 
mefhoxy vasicine (2.52), 9-acetamido-3,4-dihydropyrido[3,4-b]indole (2.53) and vasicol 
(2.54).48'49'50 
N 
N v ^ ^ N , 
COMe H O H O H 
2.50 R= H, X= H2 2.53 2.54 
2.51 R= H, X= O 
2.52 R= OMe, X= H2 
Two uterocontracting saponins ardisiacrispin A (2.55) and ardisiacrispin B (2.56) were 
isolated from the roots of Ardisia crispa. The plant is used in combination with other plants in 
Thai traditional medicines to remove dirty blood in women who suffer from menstrual pains. 
2% Aqueous acetic acid extract of the roots was found to cause contractions of the isolated rat 
uterus and that lead to the isolation of these two compounds.51 
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GHO 
2.55 R=p-D-Xyl/?(l-»- 2)-p-D-Glc/?-[ -D-Glcp(l-*~ 4)]-a-L-Arap(l-»- 3) 
2.56 R=a-L-Rha/?(l-»~ 2)-p-D-Glcp-[ -D-Glc/?(l-*~ 4)]-a-L-Ara/?(l-*-3) 
2.4 CONCLUSION 
It is clear from this review that plants are used substantially during child birth. In some plants 
the phytochemistry has been explored to identify the active uteroactive compound(s) and in 
some plants the uteroactivity could be by a synergistic effect. However, the phytochemistry of 
a large number of plants with uterotonic activity has not yet been investigated. 
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CHAPTER THREE 
PHYTOCHEMICAL STUDY OF GUNNERA PERPENSA L. 
3.1 REVIEW OF GUNNERACEAE 
Gunner a L. is a genus of herbaceous flowering plants and is the only member of the family 
Gunneraceae. Gunnera was previously placed within the family Haloragaceae due to its 
vegetative habit and the endosperm-rich seeds, but later studies on the morphology, 
anatomy, embryology and palynology accentuate the differences between Gunnera and the 
Haloragaceae taxa.1' ' 
The genus was named in honour of the Norwegian bishop and botanist Johan Ernst 
Gunnerus (1718-1773). The plant has existed for at least 95 million years and there are 
approximately 50 species mostly distributed in the southern hemisphere (Fig. 3.1). Their 
natural populations are restricted to super humid areas with heavy rainfalls, on riverbanks, 
near waterfalls and close to wells.4,5' The characteristic features of the species are long, 
slender and fleshy stems, rhubarb-like leaves and spikes with greenish flowers. Another 
characteristic feature of Gunnera shared by only few angiosperms is that it contains a 
number of separate vascular strands in the stems and petioles, which is indicative that 
Gunnera evolved from aquatic ancestors. 
The genus is interesting on an ecological and physiological basis for its remarkable 
symbiosis with cyanobacteria of the genus Nostoc} Cyanobacteria are a large, diverse and 
ancient group of prokaryotic autotrophs with an oxygenic photosynthesis and also perform 
biological nitrogen fixation, thereby using atmospheric N2 as their sole nitrogen source. 
The cyanobacterium infects specialized gland organs located on the stems of the host and 
once it has passed into the interior of the gland the cyanobacterium also enters the Gunnera 
cells where it starts to differentiate the highest frequency of nitrogen-fixing cells recorded 
for a cyanobacterium population. A good knowledge of this symbiotic relationship may be 
helpful in the development of nitrogen-fixing plants. 
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Taxonomical studies of Gunnera have been performed with the most complete 
morphological revision by Schindler in 1905.3 He divided Gunnera into five subgenera 
based on modes of propagation and geographic distribution, i.e. Perpensum, 
Pseudogunnera, Milligania, Misandra and Panke. 
FIGURE 3.1: Distribution of Gunnera 9 
The subgenus Perpensum consists of the single African species, G. perpensa L. This was 
the first species of the genus to be described and occurs in the mountains of southern 
Africa and along the Great Rift to Ethiopia and also in Madagascar. It is a medium-sized 
plant characterized by stout creeping rhizomes and reniform leaves. The inflorescences are 
large with hermaphroditic flowers (Fig 3.2). 
www.plantzafrica.com/medmonographs/gunnerapers 
FIGURE 3.2: Gunnera perpensa 
The subgenus Pseudogunnera includes a single species, G. macrophylla Blume occurring 
on the mountains of New Guinea, Solomons Islands and Sulawesi, Wallace's Line of Java, 
Sumatra, Borneo and in south-eastern Asia. It is a medium-sized plant with reniform 
leaves. It forms slender axillary stolons carrying paired opposite bracts. It is monoecious 
and the inflorescences are bisexual, with male flowers on the upper branches and female 
flowers on the lower branches. 
The subgenus Milligania includes five to seven species from New Zealand as well as the 
single Australian species, G. cordifolia Hook. f. from Tasmania (Fig 3.3). These are all 
small, mat-forming stoloniferous plants lacking scales on the stem. They are monoecious, 
with mostly unisexual, occasionally bisexual inflorescences. 
www.utas.edu.au/dicotkey/DicotKev/OTHERS/zGunntfra.htm 
FIGURE 3.3: Gunnera cordifolia 
The subgenus Misandra includes two small, stoloniferous species G. magellanica Lam. 
(Fig 3.4) from South America, characterized by a conical ochrea covering the apical bud. 
The plants are dioecious. 
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TABLE 3.1: Compounds isolated from selected Gunnera species. 
Numb. compound G. peltata G. masafuerae G. tintoria G. magellanica 
3.1 oleanolic acid + + + + 
3.2 ursolic acid - - + + 
3.3 lupeol + + + + 
3.4 erythrodiol + + + + 
3.5 urs-12-ene-
2Pt,3a-diol 
+ + + + 
3.6 vomifoliol + + + + 
3.7 liliolide + + - + 
3.8 p-sitosterol + + + + 
3.9 daucosterin + + + + 
3.10 uvaol - + 
3.11 ionone derivatives + + + 
3.12 pinoresinol + + + + 
It has been reported that an extract from the New Zealand species G. hamiltonii possesses 
strong lipoxygenase activity and that antithrombin activity was observed from an extract of 










3.2 BACKGROUND ON GUNNERA PERPENSA 
The only South African Gunnera species is Gunnera perpensa, L. known as uGobho in 
'isiZulu' and river pumpkin in English. It is widespread in Africa from Sudan, Ethiopia, 
Zaire, Rwanda, Uganda, Kenya, Tanzania, Zimbabwe, Mozambique and along the central 
and eastern areas of Southern Africa.15 It grows around the edges of the rivers and streams 
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E.J. Mendes, Haloragaceae, Ftora Zambeziaca 1978, 4, 74. 
FIGURE 3.6: Geographical distribution of G. perpensa in South Africa 
It is a rhizomatous, thinly perennial herb to 1 m in height with palmate leaves, tufted, near 
the apex of rhizome. The green flower spikes (2-10 cm long) appear in August and the 
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G. perpensa is sometimes used as an ingredient in the medicine called isihlambezo (to 
ensure the health of a mother and a child during pregnancy) and in medicine called Inembe 
(taken regularly during pregnancy to ensure easy childbirth).20 
Water, hexane and 100% ethanol extracts of dried root were assessed for in vitro 
antibacterial activity against Staphyloccocus aureus, Klebsiella pneumoniae, Bacillus 
subtilis and Escherichia coli and were found to be inactive in the concentrations used.21 
The aqueous extract have also been tested and showed the best antibacterial activity, which 
is the added advantage of its use for the treatment of wound infections. 
Motivated by the distinct red color of the stems and skin irritation on contact with the 
leaves of the plant, Drewes et al. looked at the chemical constituents of stems and leaves. 
They isolated the benzoquinones (3.13 and 3.14), a benzopyran (3.15) and a phytol (3.16). 
Compound 3.16 is reported as a mild irritant isolated from other plants, hence the skin 
irritation on handling of the plant by the authors.23 In comparing the antibacterial activity 
of the crude extracts of stems and leaves, the leaves showed higher activity than the stems. 
Amongst the compounds isolated, the benzoquinones showed good antibacterial activity. 
The leaves of the plant are used by the rural people of Eastern Cape in wound dressing.24 
3.16 
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3.3 RESULTS AND DISCUSSION 
3.3.1 Introduction 
The rhizomes of G. perpensa were collected in a wetland area in the Johannesburg suburb 
Montgomery Park. After drying and milling, the ground plant material was extracted with 
chloroform-methanol (1:1). The solvent was removed and the crude extract was subjected 
to column chromatography using solvents ranging from non-polar (hexane-ethyl acetate, 
8:2) to polar (chloroform-methanol, 9:1 to 7:3) and highly polar (ethyl acetate-water-acetic 
acid, 8:1.5:0.5). Repeated chromatography led to the isolation of P-sitosterol (3.8), Z-
venusol (3.17), methyl lespedezate (3.18), 3,3',4'-tri-0-methylellagic acid 4-0-/1-D-
glucopyranoside (3.19), and punicalagin (3.20). Apart from these compounds we have also 
isolated sucrose and another sugar which we did not identify. 
3.3.2 Structural elucidation of p-sitosterol (3.8) 
The first compound isolated exhibited twenty-nine signals in the 13C NMR spectrum (Plate 
2), which indicated that this compound might be a steroid / triterpene. The 5H NMR 
spectrum (Plate 1) had peaks characteristic of an alkene proton (8H 5.32, br. d, J = 5 Hz), 
an axial proton on an oxygen-bearing carbon (8H 3.49, broad multiplet), two tertiary methyl 
groups (5H 0.64 and 0.93) and four secondary methyl groups (8H 0.81, 0.83, 0.84 and 0.93; 
all doublets with J 7.0 Hz). These data were in agreement with the structure of the 
ubiquitous P-sitosterol (3.8). The NMR data of 3.8 (Table 3.2) is in agreement with 
published values. 
This project was started at Rand Afrikaans University, Johannesburg. After we have isolated the 
compounds and elucidated the structures, we became aware that Prof. S.E. Drewes from the University of 
KwaZulu-Natal, PMB was also investigating the phytochemistry of this plant and had isolated the same 
compounds as we did. A combined paper was published on the results (see Appendix). Punicalagin was not 




TABLE 3.2: *H- and 13C-NMR data of p-sitosterol (3.8) in CDCI3 
Experimental Literature25 
Position 5c 5H 5c SH 
1 37.2 37.2 
2 31.6 31.6 
3 71.8 3.49 (m) 71.8 3.53 (m) 
4 42.4 42.5 
5 140.7 140.7 
6 121.7 5.32 (br. d , J = 5 H z ) 121.7 5.36 (br. d , J = 5 H z ) 
7 31.8 31.8 
8 31.7 31.9 
9 50.1 50.1 
10 36.5 36.5 
11 21.1 21.1 
12 39.8 39.7 
13 42.3 42.3 
14 56.8 56.7 
15 24.3 24.3 
16 28.2 28.2 
17 56.1 56.0 
18 11.9 0.64 (s) 11.9 0.68 (s) 
19 19.4 0.93 (s) 19.4 1.01 (s) 
20 36.1 36.1 
21 19.4 0 .93(d ,J=7Hz) 18.8 0 .92(d , J=7Hz) 
22 34.0 33.9 
23 26.1 26.0 
24 45.9 45.8 
25 29.2 29.2 
26 19.8 0.83 (d, 7 = 7 Hz) 19.8 0 .83(d , J=7Hz) 
27 19.0 0.81 (d, .7=7 Hz) 19.1 0 .81(d , J=7Hz) 
28 23.1 23.0 
29 12.0 0.84 (t, J= 7 Hz) 12.0 0 .84( t , J=7Hz) 
3.3.3 Structural elucidation of Z-venusol (3.17) 
The NMR data of compound 3.17 is collated in Table 3.3. The *H NMR spectrum (Plate 
3) of this compound displayed signals with chemical shifts and coupling constants 
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characteristic of a P-D-glucopyranoside moiety (8H 3.48, 3.58, 3.72, 3.79, 4.05 and 5.11). 
The splitting pattern of anomeric proton (8H 5.11, d, J = 7.8 Hz) confirmed a p-0-
glycosidic linkage. Apart from the sugar protons, a 1,4-disubstituted benzene ring (8H 
6.77, d, J= 8.7 Hz; SH 7.66, d, J- 8.7 Hz) and an alkene proton resonating as a singlet (8H 
6.84) were also identified. 
The 13C NMR spectrum (Plate 4) displayed a total of twelve carbon signals of which the 
multiplicities were derived from an APT experiment. One CH2 carbon, eight CH carbons, 
and four non-protonated carbons were identified. In the 13C NMR spectrum six signals (5c 
62.1 to 96.2) characteristic of a glucopyranoside moiety, four aromatic signals [5c 125.9, 
5C 133.7 (2C), 5c 116.4 (2C), 8C 159.9], a non-protonated carbon at 8C 136.6 (C-2), an 
olefinic CH at Sc 120.9 and an additional non-protonated carbon 8c 162.3 were observed. 
A HSQC experiment allowed the correlation of all protonated carbon atoms with well-
resolved protons. 
In the HMQC experiment, H- C long range correlations were observed between two 
aromatic carbons (5c 133.7) and the olefinic proton (8H 6.84), which indicated that the 
olefinic proton is localized near the aromatic ring. From this information we could 
construct the structural fragment given in Fig. 3.8. 
H H 
FIGURE 3.8 
The chemical shift of the non-protonated olefinic carbon together with its observed long-
range correlation with H-l ' of the carbohydrate moiety indicates that this carbon is linked 
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FIGURE 3.9 
The ]H NMR chemical shift of H-2' of glucopyranoside has a downfield shift, which may 
be due to the presence of an acyloxy substituent on this position. By incorporating the 
unaccounted carbon atom (5c 162.5), the structure of this compound was assigned as 
venusol (3.17). NOE experiments did not give any conclusive results to assist with the 
determination of the geometry of the double bond. 
3.17 
TABLE 3.3: *H- and 13C-NMR data of Z-venusol (3.17) in CD3OD (500 MHz) 
Experimental Literature 
Position 8c 8H 




1 162.5 H-3 160.3 
2 136.6 H-3 136.0 
3 120.9 6.84, s H-5/9 117.8 
4 125.9 124.0 
5 133.7 7.66, d , J=8 .7Hz H-3 132.2 
6 116.4 6.77, d , J=8 .7Hz H-5 115.2 
7 159.9 H-5/9, H-6/8 158.3 
8 116.8 6.77, d, J= 8.7 Hz H-9 115.2 
9 133.7 7.66, d, .7=8.7 Hz H-3 132.2 
P-glucose 
1' 96.2 5.12, d , J=7 .8Hz H-2' 95.8 
T 80.1 4.05, t , J=8 .6Hz H-l ' 78.7 
3' 74.6 3.72, t , J=9 .2Hz H-2' 73.8 
4' 70.9 3.58, t , J=4 .8Hz 70.6 
5' 79.8 3.48, t ,J=9.3Hz 78.7 
6' 62.1 a. 3.79, dd,.7=5.3 Hz 
b. 3.95, d , J = 12.0 Hz 
61.6 
Unambiguous proof for the structure of Z-venusol (3.17) was provided by acetylation of 
the compound to yield venusol tetraacetate (3.21). The NMR data are given in Table 3.4. 
In the *H NMR spectrum (Plate 10), resonances of 3.21 are well resolved and the large 
coupling constants for the carbohydrate protons indicate all coupled proton pairs have a 
diaxial relationship, thereby confirming that the carbohydrate is glucose. Upon 
acetylation, a substantial shift to lower field was observed for H-3' and H-4' in the !H 
NMR spectrum thereby confirming that the hydroxy on C-2' of the glucosyl was 
derivatised in venusol (3.17). The chemical shift of the aromatic acetyl group (7-OAc) is 
clearly observed in the spectrum and is separated from the acetyl groups of the sugar. 
3.21 
TABLE 3.4: NMR data of Z-venusol tetraacetate (3.21) in CD3OD. 
Position dc 5H 
1 159.0 
2 136.2 
3 120.3 6.98, s 
4 130.0 
5 132.1 7.12, d, J =8.7 Hz 
6 121.9 7.77, d, J = 8.7 Hz 
7 151.3 
8 121.9 7.77, d, J = 8.7 Hz 
9 132.1 7.12, d, J = 8.7 Hz 
3'-OAc 20.5 2.05, s 
4'-OAc 20.6 2.09, s 
6'-OAc 20.7 2.12, s 
7-OAc 21.1 2.30, s 
P-glucose 
r 94.6 5.09, d, J = 7.9 Hz 
2' 75.6 4.32, dd, J = 9.9, 7.9 Hz 
3' 70.9 5.39, dd, J = 9.9, 9.2 Hz 
4' 67.8 5.13, J = 10.1, 9.2 Hz 
5' 73.6 3.95, ddd, J= 10.1,4.4, 2.2 Hz 
6' 61.3 a. 4.21, dd, J= 12.7, 2.2 Hz 
b. 4.32, dd, J =12.8, 4.4 Hz 
The proposed structure of venusol (3.17) was confirmed by X-ray diffraction (Prof O 
Munro, UKZN) of a single crystal provided by Prof Drewes (UKZN). The X-ray structure 
(Fig. 3.10) was in full agreement with our proposed structure and indicated that the 
geometry of the double is Z. Z-Venusol (3.17) was first isolated by Proliac et al26 from 
the leaves of Umbilicuspendulinis. 
FIGURE 3.10: X-ray structure of Z-venusol (3.17). 
3.3.4 Structural elucidation of Z-methyl lespedezate (3.18) 
During the extraction of fresh plant material, it was noticeable that when the crude extract 
was exposed to methanol for longer periods, compound 3.18 was isolated as a major 
compound with only traces of 3.17. 
The NMR data of 3.18 is summarized in Table 3.5. In the 'H NMR spectrum (Plate 14) of 
3.18, the />-disubstituted aromatic ring (SH 6.77, d, J = 8.6 Hz, H-6/8; 5H 7.74, d, J= 8.1 
Hz, H-5/9), an anomeric carbohydrate signal (5H 5.10, H-l ' , d, J = 12.5 Hz), a methoxy 
group at (5H 3.81, 3H, s) and an olefinic proton (5H 6.98) were observed. With the 
exception of the methoxy signal, the resonances were similar to that of venusol (3.17), but 
with slightly different chemical shifts. 
The 13C NMR spectrum (Plate 15) of 3.18 displays a total of thirteen carbons with an extra 
carbon compared to 3.17, which was assigned to the methyl carbon of a methyl ester at 8c 
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52.6. Other than that, signals characteristic of an 0-glucose moiety at 5c 62.5 to 102.8, a 
carbonyl carbon at 8c 166.6, four aromatic CH carbons at 8c 116.2 (C-6/8) and 133.7 (C-
5/9), three quaternary carbon at 8C 139.9 (C-2), 5C 126.7 (C-4) and 8C 159.9 (C-7) and an 
olefinic carbon at 8c 125.9 (C-3), were observed. 
The 'H-13C long-range correlations observed in an HMBC experiment showed that the 
methyl signal at 8H 3.81 was strongly correlated to the carbonyl carbon signal at 8c 166.6 
(C-l) suggesting the presence of a COOMe functionality. The correlation of H-3 at 8H 6.98 
with aromatic carbons C-5/9 demonstrates that the H-3 proton is localized near the 
aromatic ring. The same H-3 proton is further correlated to a quaternary carbon C-2 at Sc 
139.9. The fact that the C-2 carbon is further correlated to H-l ' at 8c 5.10 and is shifted 
downfield indicating that the carbon C-2 is linked to the glucose moiety through an O-
glycosidic bond. The structure of compound 3.18 was assigned as methyl lespedezate. 
Methyl lespedezate was first described by Viornery et al27 
We have observed that venusol (3.17) was transformed into methyl lespedezate (3.18) 
upon standing in methanol and the methyl lespedezate that we have isolated, is most likely 
an artifact formed during the extraction process. 
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TABLE 3.5: *H- and 13C-NMR data of methyl lespedezate (3.18) in CD3OD 
(500 MHz) 
position 5c 5H 
> 17CH correlations 
(HMQC 
1 166.6 H-3, OMe 
2 139.9 H-3 
3 125.9 6.98, s H-5/9 
4 126.7 H-6/8 
5 133.7 7.74, d, J = 8.1 Hz H-3, H-9 
6 116.2 6.77, d, J = 8.6 Hz H-8 
7 159.9 H-5/9, H6/8 
8 116.2 6.77, d, J = 8.6 Hz 
9 133.7 7.74, d, J = 8.2 Hz H-3 
OMe 52.6 3.81, s 
P-glucose 
r 102.8 5.10, d, J =12.5 Hz H-2' 
2' 75.7 3.48, t, J = 7.9 Hz 
3' 78.0 3.41, t, J = 9.0 Hz H-2', H-4' 
4' 71.4 3.34, t, J = 9.0 Hz 
5' 78.4 3.21, ddd, J =1.9, 
2.4, 3.3 Hz 
6' 62.5 a. 3.59, dd, J = 5.4, 
5.5 Hz 
b. 3.73, dd, J =1.7, 
1.8 Hz 
3.3.5 Discussion of phenyl propanoids 
Z-Venusol (3.17) was first isolated by Proliac et al26 and later by Pagani28 from leaves of 
Umbilicus pendulinis. More recently, the £-isomer was also obtained and described by 
Vionery et al21 from the same plant source. The authors were able to distinguish between 
the two isomers of venusol (3.17) using the NOE and molecular modeling experiments. 
The E- and Z- isomers of these cinnamoyl derivatives have been reported to coexist in 
nature but the Z-isomer is the more stable of the two isomers. It is believed that this 
coexistence of these isomers is probably induced by light. 
We have observed that prolonged exposure of the Z-Venusol (3.17) in MeOH results in a 
lactone methanolysis to form a methyl lespedezate 3.18 (Scheme 3.1). The relationship 
between methyl lespedezate (3.18) and lespedezic acid is a close one. Potassium 
lespedezate was a compound isolated by Viornery et al. from Lespedeza cuneata and the 
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authors were able to isolate both geometric isomers of potassium lespedezate. These two 
isomers were identified as being leaf-opening substances involved in the leaf-opening and 





3.3.6 Biosynthesis of venusol (3.17) 
No biosynthetic studies have been done on venusol (3.17). However, taking into account 
the formation of closely related compounds, a biosynthetic scheme can be proposed 
(Scheme 3.2). Transamination of tyrosine (3.22) to p-hydroxyphenylpyruvic acid (3.23) is 
followed by selective esterification between acid 3.23 and the 2-OH group of glucose to 
form 3.24. Subsequent hemiacetal formation and dehydration of the hemiacetal 3.25 will 

















3.3.7 Structural determination of 3,3',4'-tri-0-methylelIagic acid 4-0-p-D-
glucopyranoside (3.19) 
The NMR data of 3.19 is collated in Table 3.6. The 'H NMR spectrum (Plate 20) showed 
the presence of two sharp aromatic signals as singlets at 8H 7.82 and 7.61 assignable to H-5 
and H-5' of the ellagic acid moiety and six signals characteristic of the glucose moiety. 
The spectrum also revealed the presence of three aromatic methoxyl signals as singlets at 
SH 4.10, 4.03 and 3.99. 
The 13C NMR spectrum (Plate 21) displayed 22 distinct carbon resonances and some were 
separated by only few tenth of a ppm. The two most downfield resonances at 5c 158.3 and 
158.2 were assigned to the non-equivalent lactone carbonyl carbons C-7 and C-7', 
respectively. Carbons resonating at 5c 60.5, 61.3, 56.7 were attributed to the methoxyl 
carbons 3-, 3'- and 4', respectively and the signals at 5c 141.1, 140.8 and 154.2 were 
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assigned to carbons carrying methoxyl groups C-3, C-3' and C-4', respectively. The rest 
were assigned to the remaining aromatic carbons with the help of a HETCOR experiment. 
3.19 
TABLE 3.6: NMR data of 3,3',4'-tri-0-methyIelIagic acid 4-0-p-D-glucopyranoside 
(3.19) 
Experimental 












5' 107.5 7.61, s 
6' 113.5 
T 158.2 
3-OMe 60.5 4.10, s 
3'-OMe 61.3 4.03, s 
4'-OMe 56.7 3.99, s 
P-Glucose 
1" 101.2 5.05, d , J = 5.1 Hz 
2 " 77.2 5.48, dd, .7=8.0, 10.1 Hz 
3 " 73.3 5.17, t , J = 11.1 Hz 
4 " 69.4 4.57, t, .7=11.7 Hz 
5" 76.4 3.67, ddd, J =10.5, 5.7, 3.9 Hz 
6" 60.5 a. 3.50, dd, 11.7, 5.7 Hz 
b. 4.20, dd, 11.6, 4.5 Hz 
The high resolution mass spectrum of compound 3.19 revealed a molecular ion peak at 
[M]+ at m/z = 344.05434. Comparison with the spectral data reported in the literature led 
to the identification of compound 3.19 as 3,3',4'-tri-0-methylellagic acid 4-O-p-D-
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glucopyranoside, which was previously isolated from stem bark of Diplopanax 
stachyanthus. 
3.3.8 Discussion on ellagic acid derivatives 
Ellagic acid derivatives exist widely in the plant kingdom. Their biological activities have 
been studied extensively. They were reported to have aldose reductase (AR) inhibitory 
activity, DNA-gyrase inhibitory properties, inhibitory activity on HIV-1 protease, 
antihermorragic, hypotensive, sedative, antimutagenic and antioxidant properties. ' ' 
These compounds are also unique in that they possess a highly substituted biaryl nucleus 
with only two protonated carbons among a total of twelve aromatic carbon atoms. 
3.3.9 Structural elucidation of punicalagin (3.20) 
The rhizomes of G. perpensa have a distinct yellow colour. A MeOH extract of the 
rhizomes was chromatographed on Sephadex LH-20 with an EtOHiFkO (9:1, 8:2 and 7:3) 
gradient solvent system. The fraction eluted with 7:3 EtOFLF^O was rechromatographed 
on the Sephadex LH-20 with EtOH to give fraction 3.20 as a yellow amorphous powder. 
The *H NMR spectrum (Plate 23) of 3.20 indicates the presence of a number of aromatic 
protons, but at a first glance the rest of the spectrum was not informative, partly because 
the solvent peaks observed obscured part of the spectrum. 
The 13C NMR spectrum (Plate 24) revealed the presence of eight ester carbonyl carbons at 
8c 169.5-170.7, a large number of aromatic carbons and two carbohydrate moieties, which 
was identified as an a- and a (3-sugar. On closer inspection of the ' C NMR spectrum 
(Plate 24), we came to the conclusion that fraction 3.20 was in fact a mixture of two 
compounds, which were the a- and P- anomers of an acylated monosaccharide. Further 
chromatography of fraction 3.20 led to the isolation of the a-anomer (3.26). 
The NMR data of compound 3.26 are collated in Table 3.8. In the !H NMR spectrum 
(Plate 25) of 3.26 in acetone-d6, four singlets were observed in the aromatic region. In the 
region 5H 2.11-5.20 seven resonance with splitting patterns characteristic of an a-glucose 
derivative were observed {J\j, = 3.4 Hz, J2,3 = 9.7 Hz, J^= 9.4 Hz, J^5= 10.1 Hz). The 
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chemical shifts of H-2, H-3, and H-4 (5H 4.82, 5.20 and 4.78, respectively) indicate that 
these hydroxy groups of glucose are acylated. However, the most characteristic feature of 
the carbohydrate signals was the major difference in chemical shifts of the geminal 6-
methylene protons (SH 4.23 and 2.11). From the chemical shift of H-l, it was clear that C-
1 of the carbohydrate was not derivatised. The coupling constant observed for the 
anomeric carbon (J = 3.4 Hz) is characteristic of an a-anomer. 
The 13C NMR spectrum (Plate 26) of 3.26 contained four ester carbonyls (8C 170.0, 169.4, 
169.0 and 168.5), two carbon signals at 8c 158.7 and 8c 158.2 of which the chemical shifts 
were similar to C-7 and C-7' of ellagic acid derivative 3.19 described on p. 39, thirty-six 
aromatic carbon atoms and six glucose carbon atoms. The chemical shift of the anomeric 
carbohydrate carbon atom (8c 90.9) is characteristic of an a-anomer. 
Taking these data into account, we realized that this compound was most likely a 
hydrolysable tannin, which has a glucose moiety esterified with gallic acid, ellagic acid or 
derivatives thereof. A large number of these hydrolysable tannins have been described in 
the literature.32 
The correlations observed in an HMQC experiment (Table 3.7) enabled us to assign the 
structure of the ellagitannin. 
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TABLE 3.7: Correlation observed in HMQC experiment 
5H 5c 
7.01 145.9 (C-5), 145.7 (C-3), 137.1 (C-4), 124.9 (C-l), 
124.4 (C-2) 
6.58 168.5 (C-7'"), 144.8 (C-2'"), 138.4 (C-5'"), 137.6 (C-
3'"), 122.6 (C-l '") , 137.5 (C-4"'), 109.6 (C-6") 
6.59 169.4 (C-7), 145.8 (C-4), 136.8 (C-5), 127.5 (C-2), 
115.6 (C-l) 
6.50 170.7 (C-7'), 146.2 (C-4'), 145.5 (C-6'), 137.0 (C-5'), 
127.4 (C-2'), 118.9 (C-l') 
4.82 (H-2 glue.) 169.4 (C-7') 
5.20 (H-3 glue.) 170.7 (C-7') 
4.78 (H-4 glue.) 169.0 (C-7) 
3.27 (H-6 glue.) 168.5 (C-7'") 
With the exception of H-1 and H-5, each of the carbohydrate protons correlated with one 
of the ester carbonyl carbons. Furthermore, each of these four ester carbonyl carbons were 
also correlated with one of the four aromatic protons. The ellagic acid carbonyls (8c 158.7, 
158.2) are not coupled to any of the aromatic hydrogens, indicating that this moiety is fully 
substituted. From the chemical shifts, it was clear that all the aromatic rings were derived 





The gallic acid-derived ester moieties can be arranged into a hexahydroxydiphenyl 
(HHDP) moiety (Fig. 3.12) and a tetraphenyl moiety (Fig. 3.13). The long range ]H, d e -
couplings observed in the HMQC experiment for these two moieties are indicated in Fig. 
3.12 and Fig. 3.13. 
FIGURE 3.12: HMQC correlations of the HHDP moiety 
FIGURE 3.13: HMQC correlations of the tetraphenyl moiety 
It is physically impossible to link the tetraphenyl moiety to any other but C-4 and C-6 
hydroxy groups of glucose. This structural assignment was confirmed by a set of 
correlations in the HMQC experiment, where the aromatic proton that is correlated to the 
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ester carbonyl on C-6 (glue), is also correlated to one of the ellagic acid carbons [H-
6(Gluc)->ester carbonyl -> aromatic proton ->ellagic acid carbon]. 
This information allowed us to assign the structure of compound 3.26, which is that of the 
known ellagitannin punicalagin. The NMR data of a-punicalagin 3.26 is given in Table 
3.8. The NMR data obtained correlates well with those published for punicalagin,33 
although some of the assignments we made in the 13C NMR spectrum are different to the 
reported assignments. 
In an ESI-TOF mass spectrum obtained in the ESI negative mode, a peak with m/z 1083.02 
[M-H]" corresponding to a molecular formula of C48H28O30 confirmed the structural 
assignment of the compound 3.26. 
3.26 
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TABLE 3.8: NMR data of a-punicalagin (3.26) in acetone d6 
position 5c 5H position 5c 5H 
a-GIucose 
1 90.9 5.11,d, .7=3.4 6 112.4 7.01, s 
2 71.8 4.82, dd, .7= 3.6, 9.7 7 169.0 
3 77.1 5.20, t , J = 9.4, 1' 109.6 
4 75.1 4.78, t, .7=9.4 2' 115.2 
5 67.6 3.27, td, J = 10.0 3' 137.1 
6 64.9 a. 4.23, t , J = 10.7 
b. 2.11, dd, .7 = 10.1 
4' 139.7 
HDDP 5' 146.2 
1 115.6 6' 126.3 
2 127.5 T 158.2 
3 108.3 6.59, s 1 " j 115.0 
4 145.8 2 " 114.7 
5 136.8 3 " 139.0 
6 144.9 4 " 144.6 
7 169.4 5" 148.5 
r 118.6 6" 109.6 
2' 127.4 7" 158.7 
3' 108.3 6.50, s 1 '" 122.6 
4' 146.2 2 ' " 144.8 
5' 137.0 3 ' " 137.6 
6' 145.5 4 ' " 137.5 
7' 170.7 5 ' " 138.4 
tetraphenyl 
unit 
6 ' " 109.6 6.58, s 





3.3.10 Structural elucidation of p-punicalagin acetate (3.27) 
In order to confirm the structure of punicalagin, peracetate and permethyl derivatives of the 
polyphenolic compound were prepared. The anomeric mixture 3.20 was acetylated with 
acetic anhydride in the presence pyridine for 24 h at room temperature. After work up, the 
crude reaction mixture was then subjected to chromatography (hexane:EtOAc, 7.5:2.5), to 
afford a light yellow powder (3.27) in 79% yield (Scheme 3.3). The mass was established 
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to be ESI MS obtained in ESI negative mode in which m/z 1757.2 [M-H]" corresponding to 
a molecular formular of C82H62O46 was observed. 
In the 'H-NMR spectrum (Plate 30) seventeen acetyl signals at 8H 1.84-2.40, sugar protons 
at SH 2.51-6.04 and four aromatic singlets at 8H 7.24-8.06 were observed. In the
 13C-NMR 
spectrum (Plate 31), 23 signals are observed at 8c 154.57-168.19 corresponding to 23 
carbonyl carbons (seventeen acetate carbonyl carbons and six other ester carbonyl 
carbons), six sugar carbons 8c 63.9-90.0 and the rest of the carbons were assigned to the 
aryl carbons. The NMR data is collated in Table 3.9. The NMR data obtained for the 





TABLE 3.9: NMR data of p-punicalagin acetate (3.27) in CD3OD 
position 5c 5H position 5c 5H 
P-GIucose 
r 90.1 6,03, d , J = 7.5 6 119.7 8.06, s 
2' 75.7 5.10, dd, J =7.0, 10.5 7 164.6 
3' 72.8 5.19, dd, .7= 6.5, 10.5 r 119.5 
4' 73.6 4.63, d, .7= 6.4 2' 123.2 
5' 75.2 3.19, d, .7= 10.9 3' 137.3 
6 63.9 a. 4.61, t,J= 6.4 
b. 2.54, d, .7= 11.5 
4' 142.6 
HDDP 5' 144.3 
1 124.8 6' 129.0 
2 130.8 7' 154.5 
3 116.4 7.48, s 1" 123.5 
4 143.6 2" 123.1 
5 136.2 3" 142.5 
6 143.5 4" 142.7 
7 164.8 5" 144.7 
1' 126.5 6" 117.5 
2' 131.2 7" 155.0 
3' 116.2 7.31, s 1'" 127.0 
4' 143.7 2'" 142.9 
5' 136.6 3"' 141.9 
6' 143.5 4"' 139.1 
7' 165.3 5'" 142.0 
tetraphenyl 
unit 
6'" 116.7 7.22, s 





3.3.11 Structural elucidation of a- and p-punicalagin permethyl ether (3.28 and 3.29) 
Methylation of fraction 3.20 with methyl iodide and a base in acetone afforded two 
separable components which were partitioned on silica with hexane:EtOAc (8:2) to afford 
two light yellow compounds, 3.28 and 3.29, in 76% and 24% yields, respectively (Scheme 
3.4). The molecular mass of both compounds was established by ESI'-MS where [M-H]" 
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In the 'H-NMR spectum (Plates 35 and 40) seventeen methoxy signals are observed at 8H 
3.17-4.28 for a-anomer (3.28) and 8H 3.26-4.35 for P-anomer (3.29), respectively. In both 
spectra the anomeric methoxy signal is shifted upfield from the aromatic ones as expected. 
The sharp aromatic singlets corresponding to four protons are clearly observed in the 
spectra of the two compounds indicating the presence of four tetrasubstituted aromatic 
rings. The sugar moiety proton signals are also well resolved. 
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In the 13C NMR spectra of the two compounds, it was clearly observed that 3.28 differ 
from 3.29 in anomeric carbon chemical shifts with a-anomeric carbon at 8c 96.27 and the 
B-anomeric carbon resonated at 8c 100.14. In both spectra two aromatic y-lactone rings 
were also observed at 8C 155.8 (a)/ 156.43 (B) and 5C 156.9 (a)/ 156.9 (p). The 
observation of four carboxyl carbonyl carbon signals with normal chemical shifts (8c 
168.2/ 167.2, 168.2/ 167.4, 167.5/ 167.1 and 167.2/ 165.9) is consistent with the 2,3,4,6 
tetraacylation pattern of the hexopyranose moiety for each. 
The hexahydroxydiphenyl (HHDP) substructure was represented in the !H NMR spectrum 
by the aromatic protons H-3 at 5H 6.75 (a)/ 6.77 (B) and H-3' at 8H 6.68 (a)/ 6.68 (p). 
Carbons C-3 and C-3' were identified by the HSQC at 8C 104.7 and 8 104.2/104.3 
respectively. Each of the protons H-3 and H-3' of the HHDP moiety exhibited 'H-13C 
long-range correlation to an ester carbonyl carbon (C-7: 5C 168.2/167.2; C-7': 8 
168.2/167.4), two carbon corresponding to aromatic C-C bonds (C-l, C-l': 8 120.8/120.6, 
121.1/122.5; C-2: 5 128.3/128.1, C-2': 8C 129.8/128.1) and to three oxygen-bearing 
aromatic carbons (C-4, C-4': 5153.1/152.6, 153.2/153.1; C-5: 8C 131.9/130.2; C-5': 5 
140.9/132.2; C-6, C-6': 5C 152.2/152.5, 152.5/151.4. The 'H-
13C long range (Plates 39 and 
44) between the low field glucose protons H-2 (a: 5H 4.98; P: 4.91) and the HHDP 
carbonyl carbon C-7 as well as the H-3 (a: 5H 5.37, P: 5H 5.17) and C-7' indicated that the 
HHDP unit is attached to 0-2 and 0-3 of the central glucose core by ester linkages. 
1 i -i 
For the tetraphenyl unit the H- C long range correlations between the ester carbonyl 
carbon C-7 (8C 167.57/167.12) and the low field glucose protons H-4 (a: 8H 4.99; P: 8H 
4.62) along with the aromatic proton HA-6 [8H 7.34(a)/7.26(P); C-6: 8C 112.2/112.2 by the 
HSQC] indicated that the aromatic ring A is linked to the 0-4 of the glucose core. The 
remaining five ring-A carbons were identified by the HMQC at 8c 153.2/153.2, 
152.9/120.8, 127.8/126.7, 127.8/126.6 and 112.2/112.2. The aromatic ring system D was 
represented in the !H NMR by the proton HD-6'" at 8H 6.71 (a)/ 6.70 (p) (C-6'": 8C 
107.1/107.6 by HSQC). 
In the HMQC spectrum H D - 6 ' " was correlated with an ester carbonyl carbon C-7'" at 8c 
167.2/165.9 and the low field glucose protons H-6 at 8H 4.40/4.42 and 2.07/2.84 similarly 
to ring A indicated that the ring D is linked to the 0-6 of the glucose core. Once again the 
HMQC was used to identify the remaining ring-D carbons. The NMR data of the two 
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permethyl ether derivative is also in full agreement with the structure assigned to 
punicalagin. 
Although at first the structure of this hydrolysable tannin seemed to be very complex, we 
have shown here that analysis of high-field NMR spectra of punicalagin and its derivatives 
allowed us to assign an exact structure to this very complex compound. 
TABLE 3.10: NMR data of p-punicalagin permethyl ether (3.29) in CDC13 
position 8c 5H position 5c 5H 
P-Glucose 
r 100.1 4.55, d,7 = 6.9 6 112.2 
2' 74.3 4.91, dd, 7=6.9,10.4 7 167.5 
3' 75.7 5.17, dd, 7 = 8.3, 10.2 V 110.8 
4' 72.1 4.62, dd, 7= 8.1, 13.1 T 116.0 
5' 74.6 2.57, bt, 7= 4.6 3' 141.2 
6 64.4 a. 4.42, t, 7= 11.6 
b. 2.84, d, 7 = 10.6 
4' 146.0 
HDDP 5' 153.2 
1 120.6 6' 128.2 
2 128.1 T 155.8 
3 104.7 1" 116.1 
4 152.6 2 " 113.0 
5 130.2 3 " 145.6 
6 152.5 4 " 150.6 
7 167.2 5" 153.5 
r 122.5 6" 112.2 
2' 128.1 7" 156.9 
3' 104.3 1 '" 124.3 
4' 153.1 2 ' " 151.3 
5' 132.2 3 ' " 144.2 
6' 151.4 4 ' " 144.2 
7' 167.4 5 ' " 145.6 
tetraphenyl 
unit 
6 ' " 107.1 





TABLE 3.11: NMR data of a-punicalagin permethyl ether (3.28) in CDC13 
position §c 5H position 5c SH 
a-Glucose 
1' 96.2 4.70, d, J= 3.4 6 112.2 
2' 73.1 4.98, dd , J= 3.4 7 167.1 
3' 75.7 5.37, t , J = 9.3 r 110.8 
4' 70.6 4.99, d,J= 9.3 2' 115.9 
5' 66.8 3.03, X,J= 9.8 3' 141.1 
6 63.9 a. 4.40, t , J = 10.9 
b. 2.07, d , J = 10.2 
4' 145.9 
HDDP 5' 153.4 
1 120.8 6' 128.1 
2 128.3 7' 156.4 
3 104.7 1" 116.2 
4 153.1 2 " 112.5 
5 131.1 3 " 145.7 
6 152.6 4 " 146.1 
7 168.2 5" 153.5 
1' 121.1 6" 109.4 
2' 129.8 7" 156.9 
3' 104.2 1 ' " 124.3 
4' 153.2 2 ' " 150.7 
5' 140.9 3 ' " 144.2 
6' 152.5 4 " ' 144.0 
7' 168.2 5 ' " 144.8 
tetraphenyl 
unit 
6" ' 107.6 





3.3.12 Discussion on punicalagin (3.20) 
Tannins are widely distributed in higher plants and are divided into two groups, condensed 
and hydrolysable. Tannins gained originally popularity in the commercial tanning industry 
where animal hides were converted into leather by using plant extracts but have attracted 
much attention recently due to their numerous biological activities and implications in 
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potential benefits to human health. Punicalagin (3.20), a hydrolysable tannin, belongs to a 
group of polyphenols compounds called ellagitannins. 
Ellagitannins have numerous intramolecular C-C linked ester groups that have been 
located in the monomers and various intermolecular linking esters groups that have been 
defined in the formation of the oligomeric structures (Scheme 3.5). The principal members 
of these two classes of ester groups are (R)- and (5)-hexahydroxydiphenoyl (3.30), 









[hexahydroxydiphenoyl and dehydrohexahydroxydiphenoyl esters] 
(oligomers, n = 2,3,4) 





Punicalagin is the major polyphenols compound present in pomegranate and has attracted 
much recent attention due to its numerous biological activities. Pomegranate fruits are 
widely consumed fresh and in beverage forms as juice and wines. The pomegrenate juice 
has been reported to show potent antioxidant and anti-atherosclerotic properties attributed 
to its high content of polyphenols including punicalagin. Punicalagin was also found to be 
an active substance in pomegranate fruits against methicillin-resistant Staphylococcus 
aureus strains which implies antimicrobial activity.34'35 A recent review by Lansky and 
Newman highlighted the potential of plants rich in punicalagin (3.20) for the prevention 
and treatment of inflammation and cancer. 
In Taiwan the leaves of Terminalia catappa (Combretaceae) have been used as a folk 
medicine for preventing hepatoma and treating hepatitis. 7 In the leaves of this plant 
punicalagin is present as one of the hydrolysable tannins. The compound has also been 
reported to possess chemo-preventive effect on H-ras-transformed NIH3T3 cells.38 
The ellagitanins and their hydrolysis product, ellagic acid have been reported to induce 
apoptosis in tumor cells.39 They are not absorbed in vivo but reach the colon and release 
ellagic acid that is metabolized by the human microflora. Punicalagin is one of the 
hydrolysable tannins that can be hydrolyzed producing ellagic acid via spontaneous 
lactonisation of hexahydrodiphenic acid (Scheme 3.6). In this study punicalagin and 
ellagic acid were assayed on both human colon cancer Caco-2 and colon normal CCD-
112CoN cells. 
Larrosa et al.40 assayed urolithins, metabolites of punicalagin in the human body (see 
Chapter 4, p.72) to evaluate their capacity to induce cell proliferation on the estrogen-
sensitive human breast cancer MCF-7 cells as well as the ability to bind the a- and (3-
estrogen receptors and their findings were that both urolithins displayed both estrogenic 




3.3.13 HPLC study of the chemical variation of G. perpensa 
Although secondary metabolites are normally associated with specific plant species, 
chemical variation of the compounds present in a specific species is sometimes observed 
for plants collected from different geographical areas. This variation may be ascribed to 
different climatic conditions, but most often it is as a result of different genetic types of 
this species. When working with medicinal plants that grow in the wild, it is important to 
investigate the chemical variation of plants collected in different areas before making a 
general statement on the composition and activity of the plants. Therefore, we have 
decided to investigate the chemical variation of G. perpensa. 
The rhizomes of G. perpensa were collected near the streams of water in Gauteng 
(Montgomery Park, Johannesburg), two parts of KwaZulu Natal (Underberg and 
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Pietermaritzburg) and in Western Cape (Murrayburg). After drying and milling, the ground 
plant material was extracted using MeOH. 
Four extract (Underberg, Johannesburg, Pietermaritzburg and Murraysburg) and four 
compounds (3.17, 3.18 and 3.19 and 3.20) were analyzed with the reversed-phase high-
performance liquid chromatography with UV detection. The mobile phase consisted of 
ultra-pure H2O and MeOH. Fig. 3.14 to 3.21 shows the HPLC chromatograms of the four 
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FIGURE 3.20: HPLC chromatogram of a G. perpensa extract from Pietermaritzburg 
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FIGURE 3.21: HPLC chromatogram of a G. perpensa extract from Murraysburg 
In the HPLC chromatograms all the extracts (Fig. 3.18 to Fig. 3.21) of G. perpensa contain 
peaks at 2.2, 11.0, and 16.2 min. which were assigned to the isolated compounds 3.17, 3.19 
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and 3.20. However the presence of methyl lespedezate (3.18) was not observed in any of 
the crude extracts. This confirmed our earlier hypothesis that methyl lespedezate (3.18) 
isolated from the bulk extract was an artifact from the extraction procedure and 
chromatographic procedures. 
The chromatograms of the extracts from Underberg (Fig. 3.19) and Murraysburg (Fig. 
3.21) show the presence of an extra peak at 12.2 min. which is absent in the chromatogram 
of the extracts from the Johannesburg and Pietermaritzburg (Fig. 3.18 and 3.20). In the 
Murraysburg extract, the relative concentration of punicalagin (3.20) compared to the other 
metabolites, is much higher. It is clear that there is a degree of chemical variation in the 
rhizomes of G. perpensa collected in different geographical areas. 
3.3.14 Uterotonic activity of crude extract and Z-venusol (3.17) 
The uterotonic effect of the aqueous, ethyl acetate and ethyl acetate-methanol extracts of 
G. perpensa and pure venusol (3.17) were evaluated using the uterine and ileal muscle 
obtained from Sprague-Dawley rats. These experiments were done by Dr Gehring in 
collaboration with Prof. S.E. Drewes. Unfortunately Dr Gehring emigrated before 
conclusive results on the active compound in G. perpensa were achieved and the 
investigation on the biological activity was not continued. What is known is that the aq. 
extracts exhibited uterotonic contraction to both the ileum and the uterus muscle when the 
extract and the added acetylcholine were rinsed from the organ bath. The contractile 
response was reduced when acetylcholine was replaced with atropine. The organic 
extracts and pure venusol (3.17) did not induce contraction but when the test substance was 
flushed from the organ bath, venusol (3.17) did induce a state of spontaneous contractility. 
From these observations it is possible that the venusol exerts its action in conjunction with 
substances present in the whole extract. 
In this experiment, punicalagin (3.20) and ellagic acid were not evaluated for their activity. 
It is known that the active principle of Oldenlandia affinis, another African plant with 
uterotonic effect, is a cyclic peptide consisting of 29 amino acids (a cyclotide) (see Chapter 
2, p. 12). We have made an aqueous extract of G. perpensa using a procedure specific for 
the extraction of cyclotides, but did not obtain any peptide in this extract. 
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3.3.15 HIV-RT inhibitory activity of the crude extract and punicalagin (3.20) 
In a related project in our research group, the inhibitory activity of plant extracts on the 
HIV-reverse transcriptase enzyme was investigated and it was observed that at a 
concentration of 500 ug/ml the methanol extract of G perpensa inhibited the enzyme by 
97%. Bioassay-guided fractionation of the crude extracts led to the isolation of 
punicalagin (3.20) as the active compound. What is known is that tannins bind non-
selectively to proteins and that false positive results are obtained in most in vitro biological 
assays when tannins are present in the extracts that are being assayed. 
It is of interest to note that a patent on the use of G. perpensa for the treatment of immune 
system disorders (HIV) was registered recently.41 This patent describes different methods 
for the processing and extracting of the plant material, but does not give any details on the 
activity observed for the plant. 
3.4 CONCLUSION 
As can be seen from the literature review in the beginning of the Chapter, G. perpensa is 
still used widely by the indigenous people in South Africa. Prior to this study, nothing was 
known on the phytochemistry of this plant and very little was reported on the chemistry of 
the other Gunnera species. Herewith, we have presented the isolation and structural 
elucidation of secondary metabolites present in G. perpensa. All compounds isolated are 
known compounds but have not previously been reported from the genus Gunnera. The 
compounds isolated, venusol (3.17), 3,3',4'-tri-0-methylellagic acid 4-O-P-D-
glucopyranoside (3.19) and punicalagin (3.20), all have interesting biological activities. In 
the past, natural product chemists have ignored tannins in plant extracts. However, with 
the current interest in the biological activity of punicalagin,36 phytochemists need to pay 
more attention to the hydrolysable tannins when investigating medicinal plants. 
It is clear that the aqueous crude extract has an uterotonic effect but at this stage it is not 
clear which compound(s) is the active principle. Some activity have been observed for 
venusol (3.17) and it is most likely that the activity observed for the crude extract is due to 
a synergistic effect. 
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We have developed an HPLC method for the analysis of G. perpensa extracts. The 
chromatographic results obtained with extracts of plants collected in different geographical 
regions indicated that there is some chemical variation in this plant species. 
3.5 EXPERIMENTAL 
3.5.1 General 
Mass spectra were obtained with a Waters API Q-TOF Ultima LCMS or a Kratos MS 80 
RF double-focussing magnetic sector instrument. Nuclear magnetic resonance 
spectroscopy (NMR) of the isolated compounds was performed on either a Varian Unity-
Inova 300 MHz or Varian Unity-Inova 500 MHz spectrometer. All NMR spectra were 
recorded at 25 °C and the chemical shifts were recorded in ppm referenced to the solvent 
shift. Deuterated methanol (CD3OD), dimethyl sulfoxide (DMSO-de) and acetone-d6 were 
used for the polar compound and deuterated chloroform (CDCI3) was used for non-polar 
and acetylated compounds. 
Optical rotations of the isolated compounds were determined with the appropriate 
spectroscopic solvent with Perkin-Elmer 241 polarimeter. 
Thin-layer chromatography (TLC) of the crude extracts was performed with aluminum 
backed, 0.2 mm silica gel plates (Merck 0.20 mm or Machery-Nagel 0.20 mm). The TLC-
plates were visualized with the aid of UV radiation, iodine or anisaldehyde spray reagent 
(6 g anisaldehyde in 250 ml ethanol containing 2.5 ml concentrated sulfuric acid). Once 
the plates were sprayed they were heated in an oven to allow for the colour development. 
Normal and flash chromatography were performed with silica gel 60 (Merck 0.040-0.063 
mm) and on columns with diameters 4 cm and 1 cm. The extracts and mixed fractions 
were dissolved in a small amount of solvent and loaded onto the column with pipettes. 
Vaccum-liquid chromatography was carried out using Merck silica gel 60 G on columns 
with diameters of 10 cm, 4 cm and 2.5 cm. The extracts or mixed fractions were adsorbed 
onto silica and were then packed onto dry columns. The mobile phases were comprised of 
different ratios of chloroform-methanol or hexane-ethyl acetate. Both isocratic and 
gradient mobile phases were employed. 
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HPLC chromatography was performed on the Perkin Elmer Series 200 system using a 
Luna CI8 (250 x 4 mm) column and a flow rate of 3 min/ml. The following gradient 
system was used: 
Minutes MeOH H20 
0 30 70 
2 30 70 
17 70 30 
20 70 30 
23 30 70 
28 30 70 
3.5.2 Acetylation Procedure 
Acetylation of samples was performed by the addition of pyridine-acetic anhydride (1:1) to 
the sample in the round-bottomed flask. The reaction mixture was then stirred for 48 h at 
room temperature. Ethanol (3 ml) was added to react with the excess acetic anhydride. 
The resultant mixture was poured into ice-chloroform mixture and the acetylated product 
was extracted two to three times by liquid-liquid partitioning in a separating funnel. The 
organic phases were combined and the solvent removed by rotovapor evaporation. 
3.5.3 Methylation Procedure 
To a sample solution (300 mg) in dry acetone methyl iodide (1.5 ml) and K2CO3 (3.0 g) 
were added. The mixture was then refluxed in an oil bath for 5 h. The inorganic 
precipitates were filtered; the filtrate was concentrated in vacuo to remove the solvent. 
The residue was then subjected to TLC chromatography. 
3.5.4 Extraction of G. perpensa 
The rhizomes of Gunnera perpensa were collected near a stream of water in Montgomery 
Park in Johannesburg. The plant material (2 kg) was semi dried, blended with a mixture of 
1:1 CHCl3:MeOH and filtered. The filtrate was evaporated to remove the organic solvents 
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and then freeze-dried to give a light-yellow powdered crude fraction PET-1-5A (42.42 g). 
The remaining plant material was once again subjected to a blender using the same solvent 
system, filtered, organic solvents removed and freeze-dried to give a second yellow 
powdered fraction PET-1-5B (3.72 g). The plant material was then extracted twice with a 
mixture of CHC^MeOH (1:1) for a period of 18 h. Removal of the solvent by rotary 
evaporation and drying under vaccum yielded two sticky dark brown residues PET-1-5C 
(58.6 g) and PET-1-5D (14.1 g). PET-1-5C crude extract (20 g) was fractionated by 
vaccum liquid chromatography with hexane:EtOAc (9:1) as an initial eluent. The polarity 
of solvents was increased gradually and five fractions [(Frl, 400 mg), (Fr2, 74 mg), (Fr3, 
332 mg), (Fr 4, 830 mg), (Fr5, 11.69 mg)] were obtained 
3.5.5 Isolation of P-sitosterol (3.8) 
A non-polar fraction (Fr 1, 330 mg) was subjected to liquid chromatography with 
hexane:EtOAc (9.5:0.5). Three fractions were collected and one of the fractions was a 
single compound identified as p-sitosterol (3.8) (6 mg). 
3.5.5.1 Physical data for P-sitosterol (3.8) 
Description white solid 
Emperical formula C29H50O 
Melting point 137-139 °C (lit.42 139-142) 
'H NMR (CD3OD) Plate 1, Table 3.2 
13C NMR Plate 2, Table 3.2 
3.5.6 Isolation of Z-venusol (3.17) 
The crude extract (20 g) was fractionated with chloroform:MeOH (9:1) using a vaccum-
liquid chromatography to yield four fractions, one of which was .Z-venusol (3.17), 424 mg. 
3.5.6.1 Physical data for Z-venusol (3.17) 
Description white solid 













259 °C [lit.26 259-260 °C] 
[a]D
2 0+84.5(c=l,MeOH) 
Plate 3, Table 3.3 
Plate 4, Table 3.3 
Plate 5 
Plate 6 
Plate 7, Table 3.3 
Plate 8 
Plate 9 
3.5.7 Isolation of Z-venusol tetracetate (3.21) 
Z-venusol (100 mg) was acetylated according to the acetylation procedure described in 
§ 3.4.2 and after workup afforded compound 3.21 (63 mg). 
3.5.7.1 Physical data for Z-venusol tetracetate (3.21) 
Description courless oil 
Emperical formula C23H24O12 
Optical rotation [a]D
20 +25 (MeOH) 
MS m/z 492.12 
'HNMR(CD3OD) Plate 10, Table 3.4 
13C NMR Plate 11, Table 3.4 
COSY Plate 12 
HSQC Plate 13 
3.5.8 Isolation of methyl lespedezate (3.18) 
A crude fraction of 300 mg containing compound 3.17 was chromatographed (9:1, 
CHCl3:MeOH) to afford compound 3.18 (36 mg). 
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3.5.8.1 Physical data for methyl lespedezate (3.18) 
Description white solid 
Emperical formula C16H20O8 
MS m/z 340.33 
Melting point 234 °C 
Optical rotation [a]D
20 84.5 (c = 1, MeOH) 
1H NMR (CD3OD) Plate 14, Table 3.5 
13CNMR Plate 15, Table 3.5 
COSY Plate 16 
HSQC Plate 17 
HMQC Plate 18 
NOE Plate 19 
3.5.9 Isolation of 3,3',4'-tri-0-methylellagic acid 4-0-p-D-glucopyranoside 
(3.19) 
Crude extract (6.23 g) was chomatographed (hexane:EtOAc, 8:2; CHCl3:MeOH, 9:1, 8:2, 
7:3) to give four fractions. During the elution, a white precipitate was observed and was 
filtered to give compound 3.19 (5 mg). 
3.5.9.1 Physical data for -3,3',4'-tri-0-methylellagic acid 4-0-0-D-
glucopyranoside (3.19) 
Description cream white solid 
Emperical formula C23H22O13 
EI-MS m/z 343.66 
Melting point 210-211°C 
'HNMR(CD3OD) Plate 20, Table 3.6 
13C NMR Plate 21, Table 3.6 
HETCOR Plate 22 
3.5.10 Isolation of punicalagin (3.20) 
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5 g Crude extract was chromatographed on Sephadex LH-20 (120 x 4 cm) with gradient 
solvent system of EtOH-H20 (9:1-7:3) to afford 3 crude fractions: Frl (2.36 g); Fr2 (1.23 
g) and Fr3 (1.40 g). Following qualitative TLC analysis on silica gel (EtOAc-H20-
HC02H, 7:1.5:0.5). Fr3 was rechromatographed on Sephadex LH-20 using a EtOH-H20 
gradient system (9:1 - 8:2) to afford punicalagin (3.20) as a yellow amorphous powder 
(900 mg). 






'H NMR (CD3OD) 
13C NMR 
light yellow powder 
C48H28O30 
1083.02 
236-238 °C (amorphous material) 
[a]D
20 -143.4 (MeOH) 
Plate 23, Table 3.7 
Plate 24, Table 3.7 










light yellow powder 
C48H28O30 
1084.02 
234-236 °C (amorphous material) 
Plate 25, Table 3.8 




3.5.11 Isolation of p-punicalagin acetate (3.27) 
Punicalagin (3.20, 100 mg) was acetylated according to acetylation procedure described in 
§ 3.4.2. After work up, a yellow mixture was obtained, which was chromatographed 
(hexane:EtOAc, 8:2) to afford compound 3.27 (18 mg). 
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Plate 30, Table 3.9 




3.5.12 Isolation of a- and p-punicalagin permethyl ester (3.28 and 3.29) 
Punicalagin 3.20 (220 mg) was methylated according to methylation procedure described 
in § 3.4.3. After work up, the mixture was flash chromatographed (hexane:EtOAc, 9:1) to 
afford light yellow compounds 3.27 (87 mg) and 3.29 (36 mg). 
3.5.12.1 Physical data for P-punicalagin permethyl ether (3.29) 
Description light yellow powder 
Emperical formula C65H62O30 
MS m/z 1323.3130 
Melting point 201-203 °C 
'HNMR(CD3OD) Plate 35, Table 3.10 
13CNMR Plate 36, Table 3.10 
COSY Plate 37 
HSQC Plate 38 
HMQC Plate 39 
3.5.12.2 Physical data for a-punicalagin permethyl ether (3.28) 
Description 
Emperical formula 
light yellow powder 
C65H62O30 
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MS m/z 1323.3130 
Melting point 202-203 °C 
!H NMR (CD3OD) Plate 40 Table 3.11 
13C NMR Plate 41 Table 3.11 
COSY Plate 42 
HSQC Plate 43 
HMQC Plate 44 
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SYNTHESIS OF ELLAGIC ACID AND UROLITHIN 
DERIVATIVES 
4.1. INTRODUCTION 
Ellagic acid (4.1) and its derivatives exist widely in the plant kingdom and their biological 
activities have been studied extensively. Some of the derivatives were reported to have 
aldose reductase (AR) inhibitory activity, DNA-gyrase inhibitory properties, HIV-1 
protease inhibitory activity, antihermorragic, hypotensive, sedative, antimutagenic and 
antioxidant properties.1' ' These compounds are unique in that they possess a highly-
substituted biaryl nucleus with only two protonated carbons of a total of twelve aromatic 
carbon atoms. 
OR 
4.1 R = R1=H 
3.19 R = Me, R1 = glue. 
3,3',4'-tri-(9-methylellagic acid 4-O-P-D-Glucopyranoside (3.19) was first isolated from 
Diplopanax stachyanthus (Cornaceae) of Viet Nam. The authors isolated the compound 
as its acetate after acetylation of the crude plant extract. Recently it was also isolated from 
Alangium javanicum (Alangiaceae) and now we have isolated it from Gunnera perpensa 
(Gunneraceae).6 
Ellagic acid is also part of many hydrolysable tannis called ellagitannins. Punicalagin 
(3.20), which we have isolated from G. perpensa, is one such tannin that contains ellagic 
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acid. These tannins are present in many food plants, for example, punicalagin is the major 
tannin in pomegranate. It has been shown that punicalagin (3.20) from different sources is 
not absorbed in humans but is hydro lysed to yield ellagic acid (4.1), which is further 
metabolized by human colonic microflora to yield the bioavailable urolithins A (4.2) and B 
(4.3) (Scheme 4.1).7 These metabolites reach concentrations of micromolar levels in the 
blood and are excreted in the urine of humans. Urolithins have been reported to show very 
poor antioxidant activity and nothing is yet known about other (if any) potential biological 
activities in the human body.8 It was recently proposed that urolithins A (4.2) and B (4.3) 
could be used as biomarkers of human exposure to dietary ellagic acid derivatives.8 
3.20 
o^^o OH CK ^O 
4.2 4.3 
SCHEME 4.1. Metabolism of punicalagin (3.20) 
Ellagic acid (4.1) and its derivatives are strong antioxidants. The biologial activities of 
punicalagin (3.20), ellagic acid (4.1) and its derivatives and the ellagic acid metabolites 
have not been explored extensively. This may be partly due to the fact that these 
compounds are normally available only in small amounts from natural sources. The need 
for larger quantities of ellagic acid and its derivatives for biological studies, prompted us to 
investigate the synthesis of these compounds. In the next section of this chapter we give a 
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brief overview of simple ellagic acid derivatives that are widely distributed in the plant 
kingdom. 
4.2 NATURALLY OCCURING ELLAGIC ACID DERIVATIVES 
Many natural ellagic acid derivatives occur as the methyl and glycosyl analogues. Ellagic 
acid is also part of many hydrolysable tannins. In this section we will limit ourselves to the 
discussion of a number of representative methyl ethers and glycosides of ellagic acid. 
A trimethyl ether of ellagic acid was isolated from the trunk bark of Eugenia maire 
(Myrtaceae), a tree found in the lowland of New Zealand.9 Two structures (4.4 and 4.5) 
were possible for the compound and since, at that time, the authors did not have advanced 
NMR techniques available, they have used the expected ionic behavior of the free hydroxy 
groups of ellagic acid (4.1) to distinguish between these two isomers.10 The 3,3'-hydroxy 
groups of ellagic acid have a greater acidity than those in 4,4'-positions and it has been 
shown that it is possible to ionize the two pairs of hydroxy groups selectively by the use of 
bases of varying strength and obtaining the characteristic shifts of the absorption peaks in 
the ultraviolet spectrum. When the 3,3'-hydroxy groups are free, a change of the short 
wavelength peak is observed in the presence of sodium acetate but ionization of the 4,4'-
hydroxy groups requires a stronger base such as sodium ethoxide to obtain a bathochromic 
shift of the long wavelength band. The authors noticed that their phenol was unchanged in 
the presence of sodium acetate and then came to a conclusion that the free hydroxy group 
was in the 4-position. 
MeO—(\ /) (\ />— OMe M e O ~ ( \ /) (\ />— OH 
4.4 4.5 
An ellagic acid derivative, 3,3'-di-0-methylellagic acid 4-(5"-0-acetyl)-a-L-
arabinofuranoside (4.6), was isolated by Tanaka et al.l from the roots of Cornus capitata 
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Fractionation of a bark extract of Elaeocarpus masterii (Elaeocarpaceae) that exhibits 
cytotoxicity towards a human oral epidermoid carcinoma cell line led to the isolation of 
two ellagic acid derivatives, 4'-0-methylellagic acid 3-0-2",3"-di-0-acetyl-a-L-
rhamnoside (4.7) and 4,4'-0-dimethylellagic acid 3-0-2",3"-di-0-acetyl-a-L-rhamnoside 
(4.8). The two derivatives were evaluated for their cytotoxicity but they did not exhibit 




4.7 R= H 
4.8 R= Me 
Dionaea muscipula (Droseraceae) is a carnivorous plant considered to be a source of 
anticancer drugs. The methanolic extract led to the isolation of ellagic acid (4.1), 3-0-
methylellagic acid (4.9), 3,3'-di-0-methylellagic acid (4.10) and 3,3'-di-0-methylellagic 
acid 4-0-p-glucoside (4.11) and 4,4'-di-0-P-glucoside (4.12).13 
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4.1 R]=R2=R3=R4=H 
4.9 R*= R3= R4= H, R2= Me 
4.10 R1 = R4= H, R2= R4= Me 
4.11 R'= Glc, R2= R3= Me, R4= H 
4.12 R != R4= Glc, R2= R3= Me 
The rhizomes of Euphorbia acaulis (Euphorbiaceae) are used by tribes of central India for 
curing various inflammatory disorders. They are also recommended by the tribal medicine 
men for the treatment of gout and rheumatic disorder by external application. From this 
species, Bindra et alu isolated three ellagic acid derivatives, 3,3'-di-0-methylellagic acid 
4'-rutinoside (4.13), 3,3',4-tri-O-methylellagic acid 4'-rutinoside (4.14) and 3,3',4-tri-O-




4.14 R= Me 
A phytochemical study on Rhabdodendron macrophyllum (Rhabdodendraceae) revealed 
that the roots contains 3,3',4-tri-O-methylflavellagic acid (4.15) and 3,3',4-tri-O-methyl-
5'-methoxyflavellagic acid (4.16), besides other compounds isolated.15 
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4.16 R= OMe 
Qing-Mei and Xiu-Wei16 reported the isolation of a new ellagic acid derivative, 3-0-
methylellagic acid 4'-O-a-L-2"-0-acetylrhamnopyranoside (4.17) and other known ellagic 
acid derivatives from the fruits of Eucalyptus globules (Myrtaceae). 
4.17 
Bioassay-guided fractionation led to the isolation of two antioxidant and antimicrobial 
ellagic acid derivatives, 3'-0-methyl-3,4-methylenedioxyellagic acid 4'-0-glucoside-
(4.18) and pteleoellagic acid derivative 4.19 along with two other known ellagic acid 
derivatives from the stem bark of Pteleopsis hylodendron (Combretaceae). Compound 
4.18 was found to have significant antioxidant activity whilst all four compounds showed 
17 
antibacterial activity against different pathogenic bacteria. 
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Extraction and bioassay-guided fractionation of the bark of Eschweilera coriacea 
(Lecythidaceae) by Young et a/.18 led to the isolation of three ellagic acid derivatives, 
eschweilenol A (4.20), eschweilenol B (4.21) and eschweilenol C (4.22). 
4.20 4.21 4.22 
During the screening of new bioactive products from Chinese plants distributed in Yunnan, 
Yukihiro et al.19 found that a 60% ethanol extract of branches of Combretum yunnanensis 
(Combretaceae) inhibited growth of adriamycin-resistant mouse leukemia cells. Motivated 










It is clear that ellagic acid derivatives are widespread in nature and that some of them have 
pronounced biological activity. 
4.3 BIOSYNTHESIS OF ELLAGIC ACID 
Naturally-occurring ellagic acid and its derivatives are formed by the oxidative coupling of 
galloyl esters with the creation of new C-C and C-0 bonds (Scheme 4.2). The biogenetic 
pathway is initiated by oxidation of methyl gallate (4.24) by peroxidase to give dimethyl 
hexahydroxybiphenoate (4.25). The biphenyl ester is then readily transformed to the 
highly insoluble bis-lactone ellagic acid (4.1) on standing in water. This transformation is 
facilitated by the proximal juxta-position of the phenolic and ester groups on separate 
aromatic nuclei and by free rotation around the biphenyl ring.20 
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4.4 SYNTHESIS OF ELLAGIC ACID DERIVATIVES AND UROLITHIN A: A 
LITERATURE REVIEW 
4.4.1 Synthesis of ellagic acid derivatives 
Although a large number of ellagic acid derivative have been isolated from natural sources, 
only limited information on the synthesis of these compounds are available. Problems 
associated with the synthesis are the coupling of highly-substituted electron-rich aryl rings 
and difficult (9-glycosidation reactions. 
Alkylated gallic and ellagic acid derivatives have become important in studies of the 
naturally-occurring gallotannins and ellagitannins. Many partial methyl ethers of ellagic 
acid have been prepared and in some cases the reactions used have not given satisfactory 
yields of these ethers.10 The oxidation of gallic acid and its ethers by potassium persulfate 
in glacial acetic acid / sulfuric acid solution gives ellagic acid (4.1), whereas in sulfuric 
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acid alone, flavellagic acid (4.26) is formed (Scheme 4.3). Using this methodology, only 








Yukihiro et al.19 reported on the semi-synthesis of a bioactive ellagic acid derivative 
isolated from C. yunnenesis using ellagic acid (4.1) as a starting material. Selective 
benzylation of the more reactive 3,3'-hydroxy groups of 4.1 yielded 3,3'-di-0-
benzylellagic acid (4.27) and subsequent glycosidation with a L-rhamnose derivative 4.29 
and debenzylation led to the target compound 4.23 in a good yield (Scheme 4.4). 
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4.4.2. Synthesis of urolithins 
SCHEME 4.4 
.21 Hurtley reported that the condensation of 2-bromobenzoic acid (4.31) with resorcinol 
(4.32) (Scheme 4.5) proceeded smoothly in an ethanol solution in the presence of sodium 
ethoxide and either copper powder or Cu(II) sulfate as a catalyst to form urolithin B (4.3). 
Bruggink and McKillop re-examined these reaction conditions and used sodium 
hydroxide as the base; a 1:1 mixture of compound 4.3 and salicylic acid together with 
small amounts of unchanged 2-bromobenzoic acid (4.31) were formed. 
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4.31 4.32 4.3 
SCHEME 4.5 
Pandey et al. have recently used Hurtley's condensation methodology to synthesize 
urolithin A (4.2) and other substituted benzopyrones. Condensation of resorcinol (4.32) 








4.33 4.32 4.2 
SCHEME 4.6 
Alo et al.24 used a modified Suzuki cross-coupling to form a C-C biaryl bond in the 
synthesis of urolithin A (4.2) (Scheme 4.7). The aryl bromide 4.34 was subjected to 
modified Suzuki cross-coupling conditions with boronic acid 4.35 to give a biaryl 
derivative 4.36. Demethylation of 4.36 with excess BBr3 followed by acetic acid mediated 
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SCHEME 4.7 
4.5 METHODS FOR THE REDUCTIVE COUPLING OF ARYL HALIDES 
Ellagic acid derivatives often have a non-symmetrical biaryl structure. In general, the two 
methods that are the most often used for the C-C bond formation between two aryl rings 
are the Ullmann coupling and the Heck coupling reactions. 
4.5.1 Ullmann coupling methodology 
The Ullmann reaction was discovered and first reported by Ullmann and Bieleckie in 1901 
and is employed to generate a C-C bond between two aromatic nuclei.25 Two molar 
equivalents of aryl halide are reacted with one equivalent of finely divided copper at a high 
temperature (above 200 °C) to form a biaryl and a copper halide. 
The Ullmann biaryl synthesis involves an organocopper reaction intermediate (Scheme 
4.8). Its mechanism first involves the formation of an aryl copper intermediate (step A), 
where electrons are donated from copper to an aryl halide and electron-withdrawing groups 
on the aryl should stabilize this transition state. A good yield of unsymmetrical biaryls can 
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be obtained from this reaction if an activated and an unactivated aryl halide at temperatures 
too low for the latter halide alone to react (steps B and C). It is also evident that a proton 
source would suppress the Ullmann reaction and lead to reductive dehalogenation of the 
aryl halide (step D). 
ArX + 2 Cu° — S t e p A » ArCu + CuX 
step B / 
yCoxstep 
Ar-Ar + 2Cu° Ar-Ar + 2CuX ArH + Cu+ 
SCHEME 4.8 
Normally intramolecular Ullmann coupling of an aryl halide in the presence of activated 
copper at high temperatures will give a symmetrical biaryl. Dimethylformamide is a 
solvent that permits the use of lower temperatures and a lower molar proportion of copper. 
When an Ullmann coupling reaction is applied to two different aryl halides, the reaction 
rarely works well to give the unsymmetrical biaryl in good yield because of the formation 
of the symmetrically-coupled products which are difficult to separate from the desired one. 
Therefore, the use of disposable tethers will set the stage for the intramolecular Ullmann 
coupling of unsymmetrical alkyl halides and once the reaction has been conducted, the 
tether, having served its purpose, is removed.26 The primary requirements for the choice of 
a disposable tether are: 
- that the linkage should be assembled by straight-forward synthetic transformations 
from readily-available components 
- that the intramolecular reaction precursor should be stable to purification and 
subsequent reaction conditions 
- that the temporary tether should be susceptible to easy and selective cleavage. 
This approach was applied in the synthesis of (+)-<9-permethyltellium II (4.40) in which 
the key challenge was the preparation of an axially-chiral, non-racemic biaryl.27 The bis 
coupling of benzyl bromide 4.37 to (-)-hydrobenzoin afforded dibromide 4.38 in 97% 
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yield. This was followed by subsequent metal-halogen exchange, CuCN addition and 
exposure of the reaction mixture to oxygen to yield 4.39. Debenzylation to remove the 
tether led to the required product, 4.40 (Scheme 4.9). 
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Lipshutz et al.28 have used tartrate-derived tethers to prepare optically-pure binaphthyls 
(Scheme 4.10). The approach utilizes l-bromo-2-naphthol (4.41) with a tartrate derivative 
4.42 as the tether. Consecutive Mitsonubo reactions of 4.41 with 4.42 yielded 4.43. 
Treatment of 4.43 with /-BuLi followed by reaction with CuCN, and exposure to oxygen 
led to enantiomerically pure binaphthol derivative 4.44. Tether cleavage was achieved by 










3. 0 2 , 78% 
4.44 
l .NBS 
2. KOH 86% 
4.45 
SCHEME 4.10 
To effect a coupling reaction of two unsymmetrical aryl iodides, Takahashi et al.29'30 used 
salicyl alcohol as a disposable tether (Scheme 4.11). The method capitalizes on the 
differing reactivity of the phenolic and benzyl hydroxy groups. Salicyl alcohol 4.46 was 
treated with one equivalent of aryl acid halide 4.47 to give an aryl ester 4.48 which 
rearranges at ambient temperature to benzyl ester 4.49. The resulting phenol was treated 
with an aryl acid halide to give the diester 4.50. The diester was subjected to Ullmann 
coupling conditions and subsequent ester hydrolysis removed the tether giving the 
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4.5.2 Heck coupling methodology 
The Heck reaction is a palladium-catalyzed C-C coupling reaction between aryl halides or 
vinyl halides and alkenes in the presence of a base. A number of palladium catalysts are 
used in the reaction, which are either sources of palladium(O) such as Pd(PPh3)4, Pd(dba)2 
and Pd(dba)3 or sources of palladium(II) such as Pd(OAc)2 and PdCbCMeCN). 
Palladium(O) is the catalytic species in this reaction and when a palladium(II) complex is 
used, the active palladium(O) species is formed by in situ reduction, normally by reduction 
with PPh3. A wide range of high-boiling point solvents such as DMF, DMA and toluene 
are often used. Inorganic bases such as NaOAc and K2CO3 are used with polar solvents to 
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achieve homogeneity. The proposed mechanism for the reaction between an aryl bromide 
TO 
and an activated alkene is outlined in Scheme 4.12. 
SCHEME 4.12 
The intramolecular Heck reaction has been established as a powerful tool for the 
construction of complex polycyclic ring systems in natural product synthesis. 
A palladium-catalysed Heck coupling reaction was used to form an intramolecular biaryl in 
the synthesis of a gilvocarsin metabolite of a Streptomyces sp. (Scheme 4.13). In the 
synthesis of (-)-gilvocarsin M (4.55), acylation of 4.52 with acid chloride 4.53 gave an 
ester 4.54. Treatment of the ester with Pd(PPh3)2Cl2 and sodium acetate in DMA at 125 °C 
to effect the intramolecular biaryl coupling followed by hydrogenolysis resulted in the 
formation of 4.55. 
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Graphislactone C (4.60) was prepared by Abe et al. by a palladium-mediated biaryl 
coupling reaction of phenyl benzoate derivative 4.58 (Scheme 4.14). Esterification of 
phenol 4.57 with an acid 4.56 using EDC and catalytic amount of DMAP afforded phenyl 
benzoate 4.58 in 65% yield. Intramolecular biaryl coupling reaction of 4.58 with 
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Harayama and Yasuda36 synthesized arnottin 1 (4.64) isolated from Zanthoxylum 
arnottianum (Rutaceae) via intramolecular biaryl coupling reaction using a palladium 
reagent (Scheme 4.15). An ester 4.63 was prepared from an acid 4.61 and a naphthol 4.62 
using trifluroacetic anhydride. The palladium-assisted internal biaryl coupling reaction of 
4.63 resulted in the cyclised product 4.64 in a high yield. To improve the yield the authors 
examined a variety of Pd(II) reagents with or without a ligand (Table 4.1). From the table 
it can be seen that better yields can be obtained at high temperature. 
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run catalyst equiv. ligand time temp. Yield 
(%) 
of 4.64 
1 Pd(PPh3)2Cl2 0.1 — 5h 130 °C 52 
2 Pd(acac)2 0.1 PPh3 4 h 130 °C 56 
3 Pd(acac)2 0.1 PPh3 2h 150 °C 72 
4 Pd(PPh3)4 0.1 — 3.5 h 130 °C 58 
5 Pd(PPh3)4 0.1 — 2h 150 °C 71 
In conclusion, it can be seen from the literature review that both the Ullmann coupling and 
the Heck coupling reactions can be applied in the formation of the crucial biaryl bond of 
ellagic acid derivatives. 
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4.6 RESULTS AND DISCUSSION 
4.6.1 Retrosynthetic analysis 
The aim of this project was to synthesize 
(i) a non-symmetrical ellagic acid derivative that can be used for the preparation of 
3.19 
(ii) urolithins derivatives 
O 
3.19 4.2:UrolithinA 4.3: Urolithin B 
We will first discuss the synthesis of the ellagic acid derivatives. Two synthetic routes 
were followed - one that relies on the Ullmann reaction and the second one that uses the 
Heck coupling reaction and these two routes will be discussed separately. 
As can been seen from our literature overview (§ 4.5.1), the best way to prepare an 
unsymmetrical ellagic acid derivative is to use a disposable tether. In our initial approach 
we have chosen the readily-available meso-tartaric acid as the tether. The starting benzoic 
acids needed will depend on whether an Ullmann or a Heck coupling reaction is used. An 
Ullmann reaction requires two aryl halides, whereas a Heck reaction requires an aryl halide 
and an unsubstituted aryl as precursors. In both the proposed reactions, aryl bromides are 
more reactive substrates than aryl chlorides. Although aryl iodes are more reactive that aryl 
bromides, these substrates are not easily accessible and therefore we concentrated on the 
use of aryl bromides as substrates in our reactions. 
4.6.2 Preparation of starting materials for the Ullmann coupling reaction 
A retrosynthetic analysis for this route using an Ullmann coupling is given in Scheme 4.16. 
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For the esterification with diethyl tartrate, suitably protected gallic acid derivatives were 
required. At this stage we have used an acetate as a protecting group and therefore, our 
first task was to prepare 4.67 and 4.68. 
MeO 
MeO' ' y ~Br 
OAc 
4.68 
The synthesis of 3,4-diacetoxy-2-bromo-5-methoxygallic acid chloride (4.67) is outlined in 
Scheme 4.17. 
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Acid-catalyzed esterification of gallic acid (4.69) yielded methyl gallate (4.24). 
Monoalkylation of a gallic acid esters is possible by the in situ protection of two ortho-
hydroxy groups as a borate ester, which leaves the third hydroxy group free for reaction 
(Scheme 4.18).37'38 Using this methodology with dimethyl sulfate as the alkylation reagent, 
we were able to prepare monomethyl ether 4.70. 
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SCHEME 4.18 
Hydrolysis of the methyl ester 4.70 was followed by acetylation of the free hydroxy groups 
to yield diacetate 4.72 in quantitative yield. The formation of a monobrominated product 
was required in this synthesis. In our hands, a mixture of the mono- and dibrominated 
products was obtained if gallate esters were used as substrates. However, with free gallic 
acid derivatives as substrate, the exclusive formation of the monobrominated product was 
possible. Selective bromination of 4.72 afforded 4.73 in 89% yield. The 'H NMR 
spectrum of 4.73 confirmed the presence of one aromatic proton, one methoxy groups and 
two acetyl groups. In the 13C NMR spectrum the methoxy group on C-5 resonated at 8c 
57.1 and the two methyl groups of the acetyl appeared at 8c 19.9 and 20.1. The 
characteristic carbonyl signal of the acid was observed at 8c 168.4. To confirm the 
position of the bromo substituent, an NOE experiment was performed. The results showed 
a clear NOE effect between the methoxy protons and the aromatic proton, thereby 
confirming the position of the bromine. 
The acid chloride 4.67 was obtained by refluxing 4.73 in SOCI2 and after removal of the 
excess thionyl chloride, this acid chloride was used immediately in the next step without 
purification. 
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The preparation of the second acid chloride 4.68 is summarized in Scheme 4.19. Our 
starting material was the monomethylated gallic ester 4.70. Although the 4-hydroxy group 
of 4.70 is more reactive than the 3-hydroxy group, selective monomethylation was not 
possible and, therefore, a method developed by Zhu et al. ' and Pearson41 on selective 
alkylation of the 4-OH group of gallic acid was followed. This approach involves heating 
the diacetate in DMF at 40 °C in the presence of K2CO3 and Mel to give exclusively the 4-
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Hydrolysis of methyl ester followed by acetylation of the 3-hydroxy group and selective 
bromination at position 2 afforded 4.78 in 67% yield (Scheme 4.19). The !H NMR 
spectrum of 4.78 confirmed the presence of one aromatic proton, two methoxy groups and 
one acetyl group. In the C NMR spectrum the two methoxy groups at C-4 and C-5 
resonated at 8c 56.1 and 5c 61.0, one methyl of acetyl group appeared 8c 20.4. The 
characteristic carbonyl signal of the acid was observed at 5c 168.0. The acid chloride 4.68 
was obtained by refluxing 4.78 in SOCI2 and after evaporation of the excess of thionyl 
chloride, the acid chloride was used immediately in the next step without further 
purification. 
4.6.3 Ullmann coupling reactions 
In order to obtain a monoacylated tartrate, a tin-mediated acylation reaction was 
used.4 ' ' Several steps are involved in the preparation of the above starting materials 
4.67 and 4.68. (Schemes 4.18 and 4.19) and, therefore, to save starting material we have 
decided to use a model reaction first to test the effectiveness of our chosen disposable 
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tether, meso-diethyl tartrate (4.79). 2-Bromo-3,4,5-trimethoxybenzoyl chloride was 
obtained by bromination of commercially-available 3,4,5-trimethoxygallic acid followed 
by treatment of the product with thionyl chloride. Tin-mediated acylation of diethyl 
tartrate allowed the formation of the monoacylated alcohol 4.80 in 54% (Scheme 4.21). 
The !H NMR spectrum confirmed the structure of 4.80. The two backbone protons of the 
tartrate moiety had different chemical shifts - one of the protons appeared as a doublet at 
8H 5.61 (J = 2.4) caused by the anisotropic effect of the attached acyl carbonyl hydroxy 
group and the other as a broadened singlet at 8H 4.77. In the 13C NMR spectrum the carbon 
carrying a hydroxy group resonating at 5c 70.3 and the one carrying acyl group appeared at 
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SCHEME 4.21 
Subsequent acylation of the free hydroxy group of 4.80 using the same benzoyl chloride in 
the presence of a catalytic amount of DMAP afforded 4.81. The !H NMR spectrum 
confirmed the presence of diacylated product and it was observed that the two protons in 
the tartrate moiety now overlap and both appear as a singlet resonated at 8H 5.99. Since the 
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compound is symmetrical, only one set of signals representing half the molecule was 
observed in both the ]H and 13C NMR spectra. 
The diester 4.81 was subjected to Ullmann conditions (activated copper in DMF at 160 
°C), but no biaryl product could be isolated. 
In another attempt to test the effectiveness of the disposable tether under Ullmann 
conditions, it was decided to use the synthesized aryl halides 4.67 and 4.68 in the assembly 
of an unsymmetrical biaryl (Scheme 4.22). A monoacylated alcohol 4.83 was obtained by 
treating diethyl tartrate 4.78 with dibutyltin oxide and subsequent acylation with an acid 
chloride 4.67. Compound 4.83 was subjected to esterification with an acid chloride 4.68 
and a catalytic amount of DMAP to afford diester 4.84. The !H NMR spectrum is in 
agreement with the presence of the diester. Three acetoxy signals, three methoxy signals 
and two singlets in the aromatic region were observed in the spectrum. In the 13C NMR 
spectrum, a total of 12 carbons in the aromatic regions were observed suggesting the 
presence of two non-identical aromatic rings. Compound 4.84 was also subjected to 
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These results confirm that diethyl tartrate may be useful as a tether since it allow the 
suquential formation of two different aryl esters. However, with aryl bromides and under 
the reaction conditions that we have followed, the formation of a diaryl bond is not a viable 
process. 
It was decided to change the tether to salicyl alcohol as it had receive attention in the 
literature.28 Following a published method,29 salicyl alcohol (4.86) was treated with 
benzoyl chloride 4.67 in the presence of DMAP. However, we obtained only the 
diacylated product under these conditions. Therefore, we decided to use the tin-mediated 
procedure to obtain the monoacylated product. Treatment of salicylalcohol with dibutyltin 
oxide44 in THF followed by the addition of benzoyl chloride 4.67 yielded monoester 4.87 
in 77% yield (Scheme 4.23). The *H NMR spectrum is in agreement with the presence of 
the monoester as two acetoxy (8H 2.35, 2.29), one methoxy (8H 3.84), and five aromatic 
protons were observed. The benzylic proton resonances appear at SH 5.39, which is in 
agreement with the chemical shift expected for an acylated benzyl alcohol.42 In the 13C 
NMR only three carbonyl carbon signals were observed of which two at 8c 166.8 and 
166.9 can be attributed to the two acetoxy carbonyl carbons and the one at 8c 167.4 
attributed to an ester linker carbonyl carbon, thus confirming that 4.87 is indeed a 
monoester. According to the literature,30 the more reactive phenol will be acylated first at 
low temperature and, upon standing at room temperature, the product will rearrange to 
form the more stable benzylic ester. We have conducted the tin-mediated acylation 
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SCHEME 4.23 
Addition of acid chloride 4.68 to monoester 4.87 in the presence of catalytic amount of 
DMAP afforded diester 4.88 in 62% yield. The 'H NMR spectrum confirmed the presence 
of the diester, three signals in the acetoxy region, three signals in the methoxy region and 
two singlets in addition to other aromatic resonances were observed. In the 13C NMR 
spectrum, a total of 18 carbons in the aromatic region suggested the presence of two 
unsymmetrical aromatic rings with a salicyl tether. 
Once again, no coupled product was detected when an intramolecular Ullmann coupling 
reaction was attempted. Ullmann reactions notoriously require very high temperatures for 
a reaction to occur and it is possible that the temperature (160 °C) that we have used was 
not high enough. With the equipment available to us, we were unable to achieve higher 
temperatures. Our precursors in the attempted Ullmann reactions were aryl bromides. 
From the results obtained here, we can conclude that aryl bromides are not reactive enough 
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to be viable starting materials for the synthesis of ellagic acid derivatives by using Ullmann 
reactions. 
4.6.4 Heck coupling reactions 
Our second approach to the synthesis of ellagic acid derivatives was based on Heck 
coupling methodology. This approach requires the preparation of carboxylic esters for the 
intramolecular biaryl formation between two non-identical aryl rings. 
The proposed retrosynthetic analysis for the preparation of ellagic acid derivative 4.65 is 
given Scheme 4.24. The required product 4.65 can be obtained by intramolecular 
esterification of lactone 4.89. The unsymmetrical biaryl 4.89 can be accessed by 
intramolecular C-C coupling using the Heck coupling reaction of ester 4.90 as substrate. 






Our first target was the preparation of ester 4.94 (Scheme 4.25). The preparation of 
carboxylic acid 4.78 has been described in Scheme 4.19. Phenol 4.93 was prepared by the 
selective benzylation of methyl 3-O-methylgallate (4.62). Selective benzylation of 4.93 
was achieved with acetonirile as the solvent and at a lower temperature (40 °C) than is 
normally used for benzylation reactions. 
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SCHEME 4.25 
The esterification of an electron-rich benzoic acid and an electron-rich phenol is not an 
easy task. Special activating reagents such as 2-chloro-4,6-dimethoxy-l,3,5-triazine 
(CDMT) (4.96) in the presence of N-methylmorpholine (NMM)45 have been used for the 
preparation of such esters. In this reaction DMTMM (4.97), which is prepared from 
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In an attempt to prepare the carboxylic ester 4.94 in situ by reaction between carboxylic 
acid 4.78 and phenol 4.93, an unexpected novel triazine derivative was isolated when using 
the condensation reagent CDMT (4.95) in the presence of TV-methylmorpholine. The 
structure of this compound was confirmed by X-ray crystallography (Fig. 4.1). By 
considering the structure of this product, it can be concluded that in the attempted 
preparation of the condensation reagent CDMT (4.96), we have formed the monomethoxy 
derivative 4.98, and that this compound reacted with the phenol to give the undesired 
product 4.99. (Scheme 4.27). 
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In an X-ray crystal structure of 4.99, it is observed that the benzyloxy groups are 
positioned above and below the triazine ring of the molecule forming an intramolecular 
triple-decker sandwich (Fig 4.1). This compound maybe of interest since phenoxytriazine 
derivatives have been shown to form intriguing supramolecular structures when a suitable 
hydrogen-bonding substituent is present on the phenoxy ring 46,47,48 
An ester 4.94 (72%) was prepared from acid 4.78 and phenol 4.93 using trifluoroacetic 
anhydride (Scheme 4.28). The attempted palladium-assisted intramolecular biaryl 
coupling of 4.94 resulted in the cleavage of a lactone and the starting materials (4.78 and 
4.93) were formed. With the benzyl as a protecting group cleavage of the lactone while 
attempting biaryl formation, was also observed by other authors 49 
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It was clear to us that, once again, aryl bromides were not reactive enough for these 
coupling reactions, and for our final reaction we changed to an aryl iodide (Scheme 4.29). 
Another important aspect that we have considered was the protecting groups in the ring 
and have decided to use an isopropyl group instead of a benzyl group. 
2-Iodo-3,4,5-trimethoxygallic acid (4.101) was prepared by adding iodine to a solution of 
3,4,5-trimethoxygallic acid and silver trifluoroacetate. Esterification with methyl 4-0-
isopropyl-5-Omethylgallate (4.102) gave the required ester (4.103) in 92% yield. This 
ester (4.103) was then subjected to palladium-catalysed Heck coupling conditions first by 
stirring the mixture [ester (4.100), Pd(OAc)2, PPh3 and K2C03] at 60 °C (15 bar) without 
solvent for 1 h and then with DMA as a solvent for another hour. The process resulted in 
the formation of the desired biaryl lactone 4.104 in 52% yield. In the *H NMR spectrum, 
two aromatic singlets were observed at 5H 7.62 and 7.24. All five methoxy signals were 
well-resolved as compared to the methoxy resonances of ester 4.103. In the 13C NMR 
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spectrum, the characteristic carbonyl signals of the lactone was observed at 8c 160.1 
whereas the ester carbonyl resonates at 5c 169.0. 
OMe 
C02H 
0 ^ ^ / C 0 2 M e (CF3CO)20 





1. KOH, H20, heat 





Pd(OAc)2, PPh3, K2C03 
DMA, 15 bar 
SCHEME 4.29 
Hydrolysis of 4.103 in aqueous KOH followed by cyclization using trifluoroacetic 
anhydride afforded the required ellagic acid derivative 4.105 in quantitative yield. In the 
' H NMR spectrum of 4.105, only three methoxy signals were observed, two overlapping 
aromatic protons appear at 8H 7.6 and in the 13C NMR spectrum, the two lactone carbonyl 
carbons can be observed (5c 158.9 and 159.0). 
Synthesis of the punicalagin metabolite urolithin A was attempted using the Heck coupling 
reaction applied in the preparation of biaryl compound 4.104. The synthesis began with an 
esterification reaction between 2-bromo-5-methoxybenzoic acid (4.106) and 3-methoxy 
phenol 4.107 to form 4.108 in 76% yield. Attempted intramolecular Heck coupling 
resulted in a l:lmixture of products including the desired biaryl product 4.109. We then 
thought that adjusting the reaction conditions and also using another palladium catalyst 
107 
might result in the formation of only the desired product. It was observed that changing 
the catalyst from Pd(OAc)2 to Pd(PPh3)2Cl2 and decreasing the reaction time from lh to 30 
minutes, the yield of the mixture remained the same but the ratio of the desired product to 
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In the synthesis of an ellagic acid derivative, we were faced with the challenge to 
accomplish biaryl formation of two unsymmetrical electron-rich rings. In that regard, the 
Ullmann and the Heck coupling reactions were efficiently explored and it was clear that 
the Heck coupling provide a better method for the formation of the desired product. The 
problem with the Ullmann coupling is the high temperature needed to achieve coupling. 
Furthermore aryl iodides are more reactive than aryl bromides, but the bromides are more 
accessible than iodides. 
The success of the Heck coupling reaction led to the formation of a new ellagic acid 
derivative 4.105 which can be converted to the desired target molecule. We were able to 
differentiate between the hydroxy groups of gallic acid by selective protection reactions 
108 
and that provided entry to the preparation of unsymmetrical ellagic acid derivatives. The 
Heck coupling methodology also proved to be a promising method in the coupling of 
biaryls toward synthesis of the punicalagin metabolite urolithin A (4.2). 
In this research project we have managed to characterize the secondary metabolites of an 
important South African medicinal plant and have developed an analytical method to 
fingerprint the crude extract of this plant. 
We do propose that ellagic acid derivatives may play a role in the biological activity of this 
plant. Therefore, we have developed a methodology for the preparation of unsymmetrical 
ellagic acid derivatives 
4.8 EXPERIMENTAL 
4.8.1 General 
All the required chemicals or reagents were obtained from FLUKA, ALDRICH or 
MERCK and used without further purification. All solvents were purified and distilled 
before use. All reactions requiring anhydrous solvents were performed under nitrogen 
pressure. 
Thin-layer chromatography (TLC) was performed with aluminum-backed, 0.2 mm silica 
gel plates (Merck 0.20 mm or Machery-Nagel 0.20 mm). Normal and flash 
chromatography were performed with silica gel 60 (Merck 0.040-0.063 mm) and on 
columns with diameters 4 cm and 1 cm. The mobile phases were comprised of different 
ratios of chloroform-methanol or hexane-ethyl acetate. Detection of the developed TLC 
plate was accomplished using the UV254 light or by using spraying reagents. 
Nuclear magnetic resonance spectroscopy (NMR) of the isolated compounds was 
performed on either the Varian 300 MHz or 500 MHz spectrophotometer. All NMR 
spectra were recorded at 25 °C and the chemical shifts were recorded in ppm referenced to 
the solvent shift. Where required, nuclear overhauser effect (NOE) spectroscopy were 
employed to determine the position of substituents. Coupling contstants are calculated as 
observed in the *H NMR spectrum. Deuteriated methanol (CD3OD) was used for polar 
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compounds and deuteriochloroform (CDCI3) was used for non polar and acetylated 
compounds. Mass spectra were obtained with Waters API Q-TOF Ultima LCMS. Optical 
rotations of the isolated compounds were determined with the appropriate spectroscopic 
solvent with Perkin-Elmer 241 polarimeter. 
4.8.2 Synthetic procedures 
4.8.2.1 Methyl 3,4,5-trihydroxybenzoate (4.24) 
X02Me 
3,4,5-Trihydroxybenzoic acid (4.69) (10.0 g, 58.8 mmol) was dissolved in absolute 
CH3OH and cone. H2SO4 (0.3 ml) was added. After refluxing overnight, the solvent was 
evaporated to give a white solid. The residue was dissolved in ether, washed with sodium 
bicarbonate solution and brine. The organic phase was dried (MgSC^) and evaporated to 
afford methyl gallate 4.24 (10.5 g, 97%) as a white solid. 
Mp: 94-96 °C (lit.50 95-97) 
1 H NMR (CD3OD) 5H: 
13C NMR (CD3OD) 8C: 
7.03 (2H, s, H-2, H-6, ArH), 3.79 (3H, s, COCH3). 
52.2 (CO2CH3), 109.9 (2C, C-2 and C-6), 121.3 (C-l), 139.7 
(C-4), 146.4 (2C, C-3 and C-5), 169.0 (C02CH3). 
MS m/z 184.0438 
4.8.2.2 Methyl 3,4-dihydroxy-5-methoxybenzoate (4.70) 
MeCL / ^ ^C07Me 
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Methyl gallate (5.0 g, 27 mmol) was dissolved in 10% aq. sodium tetraborate decahydrate 
(borax) solution (400 ml) and stirred for 30 min. Dimethyl sulfate (15 ml) and a solution 
of sodium hydroxide (7.0 g in 50 ml of H2O) were each added dropwise to a stirred 
solution over 2.5 h and stirring was continued overnight. Cone. H2SO4 (25 ml) was added 
and stirring continued for an additional hour. The product was extracted with chloroform 
and the combined extracts were washed with 20% aq. sodium bicarbonate solution, brine, 
dried (MgSCU) and concentrated to give 4.70 (4.7 g, 85%) as a white solid. 
Mp: 131 °C (lit.51 110-111) 
*H NMR (CD3OD) 5H: 
7.32 (1H, s, H-2, H-6, ArH), 7.19 (1H, s, H-2, H-6, ArH) 
3.79 (3H, s, COCH3), 5.89 (1H, br s, OH), 5.55 (1H, br s, 
OH), 3.90 (3H, s, OCH3), 3.86 (3H, s, OCH3). 
13CNMR(CD3OD)8c: 
52.1 (CO2CH3), 56.4 (OCH3), 104.8, 110.9, 121.7, 136.8, 
143.3, 146.3 (6ArC), 166.7 (C02CH3). 
MS m/z 198.4037 
4.8.2.3 3,4-Dihydroxy-5-methoxybenzoic acid (4.71) 
OH 
To compound 4.70 (300 mg) was added KOH solution (4 g in 20 ml). The mixture was 
heated to reflux for 5h and concentrated hydrochloric acid (pH = 2) was added to give a 
white precipitate, which was filtered to give phenol 4.71 and recrystallised from benzene. 
Mp: 131 °C (lit.52 131-132 °C) 
,HNMR(CD3OD)8H: 
7.22 (1H, d, J= 2.0 Hz, H-2 or H-6, ArH), 7.17 (1H, d, J = 
2.0 Hz, H-2 or H-6, ArH), 3.84 (3H, s, OCH3). 
, 3CNMR(CD3OD)oc: 
56.4 (OCH3), 106.2, 112.0, 126.8, 141.7, 151.3, 154.2 
(6ArC), 168.9 (C02H). 
I l l 
MS m/z 185.044 





To a solution of phenol 4.71 (10.0 g, 54 mmol) in acetic anhydride (19.0 ml, 202 mmol) 
was added triethylamine (42.5 ml, 305 mmol) at 0 °C. The solution was stirred at room 
temperature for lh. The excess of acetic anhydride was destroyed by addition of EtOH (3 
ml). The reaction mixture was poured into water and extracted with EtOAc. The organic 
extracts were washed with brine, dried (MgS04) and evaporated in vacuo to give a white 
solid 4.72 (12.4 g, 100%) of diacetate. 
Mp: 
1HNMR(CD3OD)8H: 
13C NMR (CD3OD) 5C: 
MS m/z 
104 °C 
7.59 (1H, d, J = 2.0 Hz, H-2 or H-6, ArH), 7.57 (1H, d, J = 
2.0 Hz, H-2 or H=6, ArH), 3.91 (3H, s, OCH3), 2.32 (3H, s, 
OAc), 2.31 (3H, s, OAc). 
20.5 (OCOCH3), 20.7 (OCOCH3), 56.7 (OCH3), 111.4, 
117.9, 127.5, 136.8, 143.5, 152.7 (6ArC), 168.2 (OCOCH3), 
168.8 (OCOCH3) 
283.0808 
4.8.2.5. 2-Bromo-3,4-diacetoxy-5-methoxybenzoic acid (4.73) 
MeO COOH 
Bromine (11.2 ml, 220 mmol) in glacial acetic acid (25 ml) was added dropwise for a 
period of 20 min to the stirred solution of diacetate 4.72 (30.0 g, lllmmol) in glacial 
acetic acid (160 ml). Stirring was continued for 1 h. The precipitate formed during this 
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process was filtered and dried under vacuum to give 2-bromo-3,4-diacetoxy-5-
methoxybenzoic acid 4.73 (43.4 g, 89%). 
Mp: 
'HNMR(CD3OD)5H: 
13C NMR (CD3OD) 8C: 
MSw/z 
127-129 °C 
7.47 (1H, s, H-6, ArH), 3.88 (3H, s, OCH3), 2.34 (3H, s, 
OAc), 2.28 (3H, s, OAc) 
19.9 (OCOCH3), 20.1 (OCOCH3), 57.1 (OCH3), 108.3, 
112.8, 132.9, 136.9, 143.8, 152.8 (6ArC), 168.7 (OCOCH3), 
168.8 (OCOCH3) 
269.0651 




The acid 4.73 was converted to the acid chloride by boiling in SOCl2 for 5 h. After the 
reaction the SOCI2 was distilled off under vacuum to give 2-bromo-3,4,5-
trimethoxybenzoyl chloride, which was used in the next step without purification. To a 
solution of diethyl tartrate (1 g, 3.2 mmol) in THF, Bu2SnO (2 g, 9.6 mmol) was added and 
the water was separated by azeotropic distillation in a Dean-Stark apparatus for 4 h. 2-
Bromo-3,4,5-trimethoxybenzoyl chloride (840 mg, 2.7 mmol) in 1 ml THF was added 
dropwise with a syringe through a septum cap to the stirred solution. The reaction mixture 
was then stirred at room temperature for 1 h. The solvent was evaporated and the residue 
dissolved in 8 ml of anhydrous CH3CN. The solution was then cooled to 0 °C, 0.75 mmol 
of oxalic acid in 3.5 ml CH3CN was added, and the mixture was stirred at room 
temperature for 1 h. The resulting suspension was filtered under vacuum and solid washed 
several times with CH3CN. The residue was flash chromatographed (7:3 hexane:EtOAc) 
to give monoacylated alcohol 4.80 (0.83 g, 54%). 
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Mp: 
'H NMR (CDCU) 5H: 
13C NMR (CDCI3) 5C: 
MS m/z 
132-133 °C 
7.16 (1H, s, H-6, ArH), 5.61 (1H, d, J= 2.4 Hz, OHCHCO), 
4.77 (1H, s, COCHCO), 4.21 (4H, m, OCH2CH3) 3.84 (3H, 
s, OCH3), 3.79 (3H, s, OCH3) 3.79 (3H, s, OCH3), 1.15 (6H, 
m, OCH2CH3) 
13.88 (OCH2CH3), 13.94 (OCH2CH3), 56.02 (OCH3), 60.15 
(OCH3), 60.94 (OCH3), 62.05 (OCH2CH3), 62.48 
(OCH2CH3), 70.38 (OHCHCO), 73.68 (COCHCO), 109.72, 
110.55, 125.60, 146.45, 151.38, 152.18 (6ArC), 164.13 
(C02), 166.18 (C02), 170.59 (C02) 
479.0543 





The monoacylated alcohol 4.80 (1 g, 2 mmol), a catalytic amount of DMAP and 2-bromo-
3,4,5-trimethoxybenzoyl chloride (840 mg, 2.7 mmol) in THF was stirred at room 
temperature for 2 h. The reaction mixture was poured into water and extracted with 
EtOAc. The EtOAc extract was washed several times with sodium bicarbonate, brine and 
flash chromatographed (8:2 hexane:EtOAc) to give diester 4.81 (1.55g, 99%). 
' H N M R ^ D C ^ S H : 
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7.29 (2H, s, H-6, ArH), 5.99 (2H, s, COCHCO), 4.29 (4H, 
m, OCH2CH3) 3.84 (6H, s, OCH3), 3.79 (6H, s, OCH3), 3.79 
(6H, s, OCH3), 1.23 (6H, t, OCH2CH3). 
13C NMR (CDCI3) 5c: 
14.01 (OCH2CH3), 56.14 (OCH3), 60.88 (OCH3), 60.88 
(OCH3), 62.45 (OCH2CH3), 71.56 (COCHCO), 110.24, 
111.05, 125.23, 146.73, 151.48, 152.19 (6ArC), 164.06 
(C02), 165.52 (C02). 
MS/n/z 751.0227 
4.8.2.8 Diethyl 2-(3,4-diacetoxy-2-bromo-5-methoxybenzoyloxy)-3-hydroxysuccinate 
(4.83) 
o 
E t O ^ Y ° H 0 Br 
E t 0 Y^ J VV 0 A c 
OMe 
The acid 4.73 was converted to acid chloride by boiling in SOCI2 for 5 h. After the reaction 
the SOCb was distilled off under vacuum to give benzoyl chloride 4.67, which was used in 
the next step without purification. To a solution of diethyl tartrate (1 g, 3.2 mmol) in THF, 
Bu2SnO (2 g, 9.6 mmol) was added and the water was separated by azeotropic distillation 
in a Dean-Stark apparatus for 4 h. Benzoyl chloride 4.67 (900 mg, 2.5 mmol) in 1 ml THF 
was added dropwise with a syringe through a septum cap to the stirred solution. The 
reaction mixture was then stirred at room temperature for 1 h. The solvent was evaporated 
and the residue dissolved in 8 ml of anhydrous CH3CN. The solution was then cooled to 0 
°C, 0.75 mmol of oxalic acid in 3.5 ml CH3CN was added, and the mixture was stirred at 
room temperature for 1 h. The resulting suspension was filtered under vacuum and solid 
washed several times with CH3CN. The residue was flash chromatographed (7:3 
hexane:EtOAc) to give monoacylated alcohol 4.83 (0.86 g, 64%). 
Mp: 126 °C 
' H N M R ( C D C 1 3 ) 5 H : 
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13C NMR (CDCU) 5C: 
MSm/z 
7.42 (1H, s, H-6, ArH), 5.66 (1H, d, J = 1.5 Hz, OHCHCO), 
4.82 (1H, d, J= 1.5 Hz, COCHCO), 4.25 (4H, m, OCH2CH3) 
3.85 (3H, s, OCH3), 2.32 (3H, s, OAc) 2.28 (3H, s, OAc), 
1.24 (6H,m, OCH2CH3). 
13.8 (OCH2CH3), 13.8 (OCH2CH3), 19.8 (OCOCH3) 19.9 
(OCOCH3), 56.2 (OCH3), 62.0 (OCH2CH3), 62.4 
(OCH2CH3), 70.2 (OHCHCO), 73.8 (COCHCO), 108.5, 
112.4, 128.2, 136.3, 142.45, 151.02 (6ArC), 163.22 (C02), 
165.90 (C02), 166.65 (C02), 166.84 (C02), 170.38 (C02) 
535.0441 





To the solution of phenol 4.70 (10.0 g, 50 mmol) in acetic anhydride (19.0 ml, 202 mmol) 
at 0 °C, triethylamine (42.5 ml, 305 mmol) was added. The solution was stirred at room 
temperature for 1 h. The excess of acetic anhydride was destroyed by addition of EtOH (3 
ml). The reaction mixture was poured into water and extracted with EtOAc. The organic 
extracts were washed with brine, dried (MgS04) and evaporated in vacuo to give 4.74 
(14.2 g, 100%) of diacetate. 
'H NMR (CD3OD) 8H: 
13C NMR (CD3OD) 8c: 
MS m/z 
7.54 (1H, d, J = 1.5 Hz, H-2 or H-6, ArH), 7.50 (1H, d, J = 
1.5 Hz, H-2 or H-6, ArH), 3.90 (3H, s, OCH3), 3.88 (3H, s, 
CO2CH3), 2.31 (3H, s, OAc), 2.24 (3H, s, OAc). 
20.2 (OCOCH3), 20.5 (OCOCH3), 52.4 (C02CH3), 56.4 
(OCH3),110.7, 116.9, 128.2, 135.8, 143.1, 152.3 (6ArC), 
167.2 (C02), 168.0 (C02). 
283.0808 
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The mixture of the diacetate 4.74 (10.0 g, 35 mmol), K2C03 (15 g, 101 mmol) and CH3I 
(4.5 ml, 105 mmol) in DMF was heated at 40 °C for 8 h. The inorganic salt was filtered 
out and the filtrate was diluted with EtOAc. The organic extract was washed several times 
with water to remove most of the DMF, dried (MgSC^), evaporated and flash 
chromatographed (9:1 hexane:EtOAc) to afford 4.75 (8.6 g, 96%). 
'H NMR (CD3OD) 5H: 
13C NMR (CD3OD) 5C: 
MSm/z 
7.39 (1H, d, J= 1.5 Hz, H-2 or H-6, ArH), 7.28 (1H, d, J = 
1.5 Hz, H-2 or H-6, ArH), 3.91 (3H, s, OCH3), 3.89 (3H, s, 
OCH3), 3.88 (3H, s, C02CH3), 2.32 (3H, s, OAc). 
20.5 (OCOCH3), 52.1 (CO2CH3), 56.1 (OCH3) 60.7 (OCH3), 
111.2, 117.0, 125.0, 143.4, 145.1, 153.1 (6ArC), 165.9 
(C02), 168.8 (C02). 
255.0858 
4.8.2.11 3-Hydroxy-4,5-dimethoxybenzoic acid (4.76) 
M e O ^ ^ / C 0 2 H 
JLJ 
M e O " ^ ^ 
OH 
Compound 4.75 (2 g, 7.9 mmol) was added to a KOH solution (4 g 20 ml). The mixture 
was heated to reflux for 5h and hydrochloric acid (pH = 2) was added to give a white 
precipitate, which was filtered and recrystallised from benzene to give phenol 4.76. 
Mp: 
]H NMR (CD3OD) 5H: 
52 185-186 °C (lit." 184-185 °C) 
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7.20 (1H, d, J= 1.8 Hz, H-2 or H-6, ArH), 7.18 (1H, d, J = 
1.8 Hz, H-2 or H-6, ArH), 3.86 (3H, s, OCHj), 3.84 (3H, s, 
OCH3). 
13CNMR(CD3OD)5c: 
56.3 (OCH3), 60.9 (OCH3), 106.0, 112.1, 126.9, 141.7, 
151.3, 154.1 (6ArC), 168.9 (C02H). 
MSm/z 199.0596 
4.8.2.12 3-Acetoxy-4,5-dimethoxybenzoic acid (4.77) 
M e O - _ ^ . C 0 2 H 
To the solution of phenol 4.76 (1 g, 5 mmol) in acetic anhydride (1.9 ml, 20.2 mmol) was 
added triethylamine (4.3 ml, 30.5 mmol) at 0 °C. The solution was stirred at room 
temperature for 1 h. The excess of acetic anhydride was destroyed by addition of EtOH (3 
ml). The reaction mixture was poured into water and extracted with EtOAc. The organic 
extracts were washed with brine, dried (MgSCU) and evaporated in vacuo to give 4.77 as a 
white solid (1.2 g, 100%) of diacetate. 
Mp: 78-79 °C 
!H NMR (CD3OD) 8H: 
7.25 (1H, d, J= 1.5 Hz, H-2 or H-6, ArH), 7.16 (1H, d, J = 
1.5 Hz H-2 or H-6, ArH), 3.84 (3H, s, OCH3), 3.83 (3H, s, 
OCH3). 
13, C NMR (CD3OD) 5C: 
20.53 (OCOCH3), 55.8 (OCH3) 60.7 (OCH3), 105.3, 109.9, 
125.3, 139.4, 148.9, 151.8 (6ArC), 166.6 (C02H). 
MSm/z 241.0668 
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Bromine (11.2 ml, 220 mmol) in glacial acetic acid (25 ml) was added dropwise for a 
period of 20 min to the stirred solution of monoacetate 4.77 (30.0 g, lllmmol) in glacial 
acetic acid (160 ml). Stirring was continued for 1 h. The precipitate formed during this 
process was filtered and dried under vacuum to give 4.78 (43.4 g, 89%). 
Mp: 
1HNMR(CD3OD)6H: 
13 C NMR (CD3OD) 8C: 
MS m/z 
165-166°C 
10.17 (1H, brs, COOH), 7.52 (1H, s, H-6, ArH), 3.89 (6H, s, 
OCH3), 2.38 (3H, s, OAc). 
20.4 (OCOCH3), 56.1 (OCH3) 61.0 (OCH3), 110.0, 113.6, 










The acid 4.78 was converted to the acid chloride 4.68 by boiling it in SOCI2 for 5 h. After 
the reaction the SOCI2 was distilled off under vacuum to give benzoyl chloride 4.68, which 
was used in the next step without purification. 
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The monoacylated alcohol 4.83 (1 g, 1.8 mmol), a catalytic amount of DMAP and benzoyl 
chloride 4.68 (780 mg, 2.3 mmol) in THF was stirred at room temperature for 2 h. The 
reaction mixture was poured into water and extracted with EtOAc. The EtOAc extract was 
washed several times with sodium bicarbonate, brine and flash chromatographed (8:2 
hexane:EtOAc) to give diester 4.84 (1.2 g, 78%). 
' H N M R ( C D C 1 3 ) 5 H : 
13, C NMR (CDCl3) 5C: 
MS m/z 
7.52 (1H, s, H-6, ArH), 7.49 (1H, s, H-6\ Ar'H), 6.00 (2H, s, 
COCHCO), 4.24 (4H, m, OCH2CH3) 3.86 (3H, s, OCH3), 
3.82 (3H, s, OCH3), 3.80 (3H, s, OCH3) 2.34 (3H, s, OAc) 
2.27 (3H, s, OAc), 2.00 (3H, s, OAc), 1.23 (6H, m, 
OCH2CH3) 
13.8 (OCH2CH3), 19.9 (OCOCH3) 20.17 (OCOCH3), 20.74 
(OCOCH3) 56.0 (OCH3), 56.3 (OCH3), 60.1 (OCH3), 60.8 
(OCH2CH3), 62.4 (OCH2CH3), 71.4 (OHCHCO), 71.7 
(COCHCO), 108.9, 109.3, 112.8, 113.3, 124.3, 127.8, 136.5, 
142.5, 142.7, 145.7, 151.6 (ArC), 163.1 (C02), 165.1 (C02), 
165.2 (C02), 166.6 (C02), 166.8 (C02), 167.6 (C02), 166.8 
(C02), 
849.0268 
4.8.2.15 2-Hydroxybenzyl 3,4-diacetoxy-2-bromo-5-methoxybenzoate (4.87) 
Br O f |j 
AccAf 
OMe 
The acid 4.73 was converted to acid chloride 4.67 by boiling in SOCb for 5 h. After the 
reaction the SOCI2 was distilled off under vacuum to give benzoyl chloride 4.67, which 
was used in the next step without purification. To a solution of salicyl diol (1 g, 8 mmol) in 
THF was added Bu2SnO (2 g, 9.6 mmol), after addition water was separated by azeotropic 
distillation in a Dean-Stark apparatus for 4 h. Benzoyl chloride 4.67 (800 mg, 2.2 mmol) 
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in 1 ml THF was added dropwise with a syringe through a septum cap to the stirred 
solution. The reaction mixture was then stirred at room temperature for 1 h. The solvent 
was evaporated and the residue dissolved in 8 ml of anhydrous CH3CN. The solution was 
then cooled to 0 °C, 0.75 mmol of oxalic acid in 3.5 ml CH3CN was added, and the mixture 
was stirred at room temperature for 1 h. The resulting suspension was filtered under 
vacuum and solid washed several times with CH3CN. The residue was flash 
chromatographed (hexane:EtOAc, 7:3) to give monoacylated alcohol 4.87 (0.77 g, 77%). 
Mp: 
' H N M R ( C D C 1 3 ) 5 H : 
13 C NMR (CDCI3) 5C: 
MS m/z 
127-130 °C 
7.38 (1H, s, H-6, ArH), 7.34 (1H, dd, J= 8.3, 1.5 Hz, ArH), 
7.29 (2H, m, ArH), 6.93 (1H, dd, J= 7.5 Hz, ArH), 5.39 (2H, 
s, ArCFb), 3.84 (3H, s, OCH3), 2.35 (3H, s, OAc), 2.29 (3H, 
s, OAc). 
20.1 (OCOCH3), 20.2 (OCOCH3), 56.5 (OCH3), 64.3 
(ArCH2), 108.8, 112.5, 117.4, 120.6, 121.2, 129.3, 131.0, 
131.9, 136.4, 142.6, 151.2, 155.3, (12 ArC), 166.8 (C02R), 









The monoacylated alcohol 4.87 (lg, 2.2 mmol), a catalytic amount of DMAP and benzoyl 
chloride 4.68 (800 mg, 2.4 mol) in THF was stirred at room temperature for 2 h. The 
reaction mixture was poured into water and extracted with EtOAc. The EtOAc extract was 
washed several times with sodium bicarbonate, brine and flash chromatographed 
(hexane:EtOAc, 8:2) to give diester 4.88 (1.03 g, 62%). 
Mp: 
' H N M R ( C D C 1 3 ) 5 H : 
13C NMR (CDC13) 5C: 
MS m/z 
104-106 °C 
7.60 (1H, dd, J= 11.1, 1.2 Hz, ArH), 7.54 (1H, s, ArH), 7.48 
(1H, td, J = 8.0, 1.3 Hz, ArH), 7.33 (1H, t, J = 7.5, ArH), 
7.29 (1H, d, J = 8.2, ArH), 7. 32 (1H, s, H-6\ ArH), 5.42, 
(2H, s,ArC]Hb), 3.92 (3H, s, OCH3), 3.83 (3H, s, OCH3), 3.79 
(3H, s, OCH3), 2.40 (3H, s, OAc), 2.33 (3H, s, OAc), 2.28 
(3H, s, OAc). 
20.1 (OCOCH3), 20.2 (OCOCH3), 20.4 (OCOCH3), 56.2 
(OCH3), 56.5 (OCH3), 61.0 (OCH3), 62.9 (ArCH2), 108.5, 
109.4, 112.3, 112.9, 122.7, 125.3, 126.5, 127.4, 129.4, 130.2, 
130.8, 131.1, 142.5, 143.1, 145.8, 149.4, 151.2, 152.1 (18 
ArC), 163.7 (C02C03), 164.5 (C02CH3), 166.8 (OCOCH3), 
167.0 (OCOCH3), 167.8 (OCOCH3). 
753.5036 





Methyl 3,4-dihydroxy-5-methoxybenzoate (4.70) (5 g, 0.108 mol) and K2C03 (7.5 g, 0216 
mol) were added to acetonitrile (100 ml). Benzyl bromide (2.5 ml) was added and the 
mixture was heated for 1.5 h at 50 °C. After cooling, the mixture was poured into water 
and (100 ml) and extracted several times with EtOAc. The EtOAc extracts were washed 
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with water, dried (MgSCU), concentrated and chromatographed (9:1 hexane:EtOAc) to give 
4.93 (7.4 g. 83%) as a white solid. 
Mp: 
' H N M R ( C D C 1 3 ) 5 H : 
13C NMR (CD3OD) 5C: 
MS m/z 
74-76 °C 
7.38 (5H, m, ArCH2) 7.26 (1H, d, J= 1.5 Hz, H-2 or H-6, 
ArH), 7.22 (1H, d, J = 1.9 Hz, H-2 or H-6), 5.77 (1H, s, OH), 
5.15 (2H, s, ArCHs), 3.94 (3H, s, OCH3), 3.88 (3H, s, 
CO2CH3). 
52.1 (CO2CH3), 55.9 (OCH3) 75.2 (ArCH2), 105.4, 109.8, 
125.7, 128.4(2x), 128.6(2x), 136.7, 138.1, 149.2, 151.9 
(12ArC), 166.6 (C02). 
289.1721 
4.8.2.18 2,4-Dichloro-6-methoxy-l,3,5-triazine (4.98) 
MeO 
CI 
A mixture of 100 ml methanol, 13.5 ml water and (16.5 g, 0.2 mol) sodium bicarbonate 
was cooled to 10-15 °C. Cyanuric chloride (18.4 g, 0.1 mol) was added and the resulting 
mixture was warmed to 35 °C then stirred at the same temperature for 30 min. Water was 
added to the reaction mixture and the precipitated product filtered under vacuum, washed 
with water and dried under vacuum to yield 2,4-dichloro-6-methoxy-l,3,5-triazine (4.98) 
as a white solid (5.2 g, 28%) 
Mp: 
'HNMR(CDCl3)8H: 
13C NMR (CD3OD) 8C: 
MS m/z 
81-83 (lit.53 80-90) 
4.12 (3H, s, OMe). 







A solution of compound 4.98 (72 mg, 0.40 mmol) and compound 4.93 (58 mg, 0.20 mmol) 
in THF (20 ml) was stirred under nitrogen. N-Methylmorpholine (24 mg, 0.24 mmol) was 
added and, after stirring for 4 h, the reaction mixture was poured into water and extracted 
with ethyl acetate. The organic phase was washed successively with saturated NaHCC>3 
solution, water, IN HCl, water, brine and dried (MgS04). The crude product was 
chromatographed (hexane:EtOAc, 7:3) to afford 4.99 (92 mg, 67%) as a cream white solid. 
Recrystallisation by slow evaporation of a methanol solution of 4.99 gave the compound as 
colourless crystals. 
Mp: 
' H N M R ^ D C ^ S H : 
13C NMR (CD3OD) 5C: 
MSm/z 
98-100 °C 
7.51 (1H, d, J = 1.9 Hz, H2 or H6), 7.43 (1H, d, J = 1.9 Hz, 
H-2or H-6, ArH), 7.23-7.25 (10H, m, ArCH2), 5.06 (4H, s, 
ArCHs), 3.92 (6H, s, C02CH3), 3.90 (6H, s, OCH3), 3.77 
(3H, s, OMe). 
52.2 (2x CO2CH3), 55.4 (OCH3), 56.2 (OCH3), 74.8 
(ArCH2), 111.2(2x), 116.8(2x), 125.2(2x), 127.6(2x), 
127.8(4x), 128.2(4x), 136.9(2x), 144.0(2x), 153.3(2x) 









To a suspension of 2-bromo-3-acetoxy-4,5-dimethoxybenzoic acid (4.78) (200 mg, 0.360 
mmol) in dry benzene (3 ml), trifluoroacetic anhydride (0.06 ml, 0.425 mmol) was added. 
After stirring for 2 h at 60 "C, a solution of methyl 4-benzyloxy-3-hydroxy-5-
methoxybenzoate (100 mg, 0.359 mmol) in dry benzene (3 ml) was added to the mixture 
and stirred for 2 h at 60 °C. The reaction mixture was cooled to room temperature and then 
diluted with EtOAc. After neutralization with 5% NaOH aqueous solution and extracted 
with EtOAc, the obtained EtOAc layer was washed with brine, dried (MgS04), 
concentrated and flash chromatographed (hexane:EtOAc, 9:1) to give 4.94 (202 mg, 72%) 
as a light-yellow solid. 
Mp: 
' H N M R C C D C ^ S H : 
13 C NMR (CDC13) 6C: 
MSm/z 
67-68 °C 
7.58 (1H, d, J = 2.0 Hz, H-2' or H-6\ ArH), 7.55 (1H, d,J = 
2.0 Hz, H-2' or H-6', ArH), 7.36 (1H, s, H-6) 7.22 (5H, m, 
ArCH2), 5.14 (2H, s, ArCHj), 3.96 (3H, s, OCH3), 3.91 (3H, 
s, OCH3), 3.90 (3H, s, OCH3), 3.72 (3H, s, OCH3), 2.40 (3H, 
s, OAc). 
52.2 (CO2CH3), 56.0 (OCH3), 56.2 (OCH3), 61.0 (OCH3), 
74.9 (ArCH2), 109.6, 111.5, 113.2, 117.0, 125.3, 127.9, 
128.1(2x), 128.2(2x), 136.8, 142.9, 143.6, 144.1, 145.6, 




4.8.2.21 Methyl 4-isopropoxy-3-hydroxy-5-methoxybenzoate (4.102) 
HO C02Me 
Methyl 3,4-dihydroxy-5-methoxybenzoate (4.70) (2 g, 10 mmol) and K2C03 (7.5 g, 54 
mmol) were added to acetonitrile (100 ml). Isopropyl bromide (10 ml) was added and 
mixture was refluxed for 2 h. After cooling, the mixture was poured into water (100 ml) 
and extracted several time with EtOAc. The EtOAc extracts were washed with water, 
dried (MgSCU), concentrated and chromatographed (hexane:EtOAc, 9:1) to give 4.102 (2.2 
g, 92%) as a white solid. 
Mp: 
*H NMR (CDC13) 5H: 
MS m/z 
13-14 °C 
7.29 (1H, d, J = 2.0 Hz, H-2 or H-6, ArH), 7.17 (1H, d, J = 
1.9 Hz, ArH), 5.96 (1H, s, OH), 4.68 [1H, sept, OCH(CH3)2], 
3.86 (3H, s, CO2CH3), 3.86 (3H, s, OCH3), 1.29 [6H, d, J= 
6.2 OCH(CH3)2]. 
263.0924 







To a suspension of 2-iodo-3,4,5-trimethoxybenzoic acid (4.101) (2 g, 5.9 mmol) in dry 
benzene (9 ml), trifluoroacetic anhydride (0.18 ml, 1.28 mmol) was added. After stirring 
126 
for 2h at 60 °C, a solution of Methyl 3-hydroxy-4-isopropoxy-5-methoxybenzoate (4.102) 
(1 g, 3.59 mmol) in dry benzene (9 ml) was added to the mixture and stirred for 2 h at 60 
°C. The reaction mixture was cooled to room temperature and then diluted with EtOAc. 
After neutralization with 5% NaOH aqueous solution and extracted with EtOAc, the 
obtained EtOAc layer was washed with brine, dried (MgS04), concentrated and flash 
chromatographed (hexane:EtOAc, 9:1) to give 4.103 (2.3 g, 70%) as a light yellow solid. 
Mp: 
' H N M R ( C D C 1 3 ) 5 H : 
13C NMR (CDC13) 8C: 
MS m/z 
82-83 °C 
7.57 (1H, d, J= 1.8 Hz, H-2' or H-6', ArH), 7.53 (1H, d, J = 
1.7 Hz, H-2' or H-6', ArH) 7.48 (1H, s, H-6, ArH), 4.67 [1H, 
sept, OCH(CH3)2] 3.95 (3H, s, C02CH3), 3.92 (6H, s, 
OCH3), 3.89 (6H, s, OCH3), 1.24 [6H, d, J = 6.2 Hz, 
OCH(CH3)2]. 
22.7 [OCH(CH3)2], 52.2 (C02CH3), 56.2 (OCH3), 56.3 
(OCH3) 60.8 (OCH3), 61.0 (OCH3), 75.8 [OCH(CH3)2], 85.0 
111.1, 111.2, 117.3, 124.6, 129.2, 143.3, 144.1, 145.5, 153.2, 









A mixture of ester 4.103 (1 g, 1.8 mmol), Pd(OAc)2 (45 mg, 0.27 mmol), PPh3 (110 mg, 
0.42 mmol) and K2C03 (360 mg, 2.6 mmol) was heated at 10 bar for 1 h at 60 °C. Freshly 
distilled 7V,iV-dimethylacetamide (DMA) was added and the reaction mixture re fluxed at 
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130 °C for 1 h. The mixture was allowed to cool to room temperature and diluted with 
EtOAc washed sequentially with 2 M HCI, brine, dried (MgSCU), concentrated in vacuo 
and flash chromatographed on silica gel (9.5:0.5 CHCl3:EtOAc) to give 4.104 (400 mg, 
52%). 
Mp: 
'H NMR (CDC13) 8H: 
13C NMR (CDCI3) 8C: 
MS m/z 
112-113 °C 
7.64 (1H, s, H-6, ArH), 7.24 (1H, s, H-6', ArH), 4.68 [1H, 
sept, OCH(CH3)2] 4.03 (3H, s, OCH3), 3.99 (3H, s, OCH3), 
3.95 (3H, s, OCH3), 3.76 (3H, s, OCH3), 3.59 (3H, s, OCH3) 
1.40 [6H, d, J= 6.2 Hz, OCH(CH3)2]. 
22.5 [OCH(CH3)2], 52.0 (OCH3), 52.2 (C02CH3), 56.2 
(OCH3), 56.3 (OCH3), 61.1 (OCH3), 61.2 (OCH3), 76.7 
[OCH(CH3)2], 107.6, 108.8, 110.1, 117.4, 122.9, 126.1, 
136.5, 145.6, 148.3, 150.0, 152.9, 153.7 (12 ArC), 160.2 
(C02), 169.0 (C02CH3). 
447.1695 




To compound 4.104 (300 mg, 0.68 mmol), KOH solution (2 g in 20 ml) was added. The 
mixture was heated to reflux for 5h and concentrated hydrochloric acid (Ph = 2) was added 
to give a white precipitate, which was filtered to give diacid and was used in the next step 
without purification. A mixture of diacid (30 mg, 0.068 mmol) and CF3C020 (1 ml) in 
C6H6/CH2C12 1:1 (2 ml) was stirred at room temperature for 6h. Evaporation of solvents 
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13 C NMR (CDC13) 5C: 
MS m/z 
137-138 °C 
7.69 (2H, s, H6 & H-6\ ArH), 4.85 [1H, sept, OCH(CH3)2] 
4.22 (3H, s, OCH3), 4.03 (3H, s, OCH3), 4.01 (3H, s, OCH3), 
1.43 [6H, d, J= 6.2 Hz, OCH(CH3)2]. 
22.6 [OCH(CH3)2], 56.7 (OCH3), 56.8 (OCH3), 60.3 (OCH3), 
76.9 [OCH(CH3)2], 107.7, 107.8, 112.3, 112.4, 113.3, 113.5, 
140.3, 141.1, 141.8, 142.1, 154.3, 155.3 (12 ArC), 158.9 
(C02), 159.0 (C02). 
380.3732 
4.8.2.25. 3-Methoxyphenyl 2-bromo-5-methoxybenzoate (4.108) 
To a suspension of 2-bromo-5-methoxybenzoic acid (4.106) (1 g, 2.9 mmol) in dry 
benzene (3.5 ml), trifluoroacetic anhydride (0.06 ml, 1.28 mmol) was added. After stirring 
for 2 h at 60 °C, a solution of 3-methoxyphenol (4.107) (0.5 g, 3.59 mmol) in dry benzene 
(3.5 ml) was added to the mixture and stirred for 2 h at 60 °C. The reaction mixture was 
cooled to room temperature and then diluted with EtOAc. After neutralization with 5% 
NaOH aqueous solution and extracted with EtOAc, the obtained EtOAc layer was washed 
with brine, dried (MgS04), concentrated and flash chromatographed (9:1 hexane:EtOAc) 
to give 4.108 (2.3 g, 76%) as a yellow oil. 
' H N M R ( C D C 1 3 ) 5 H : 
7.58 (1H, d, J= 8.8 Hz, ArH), 7.51 (1H, d, J = 3.1 Hz, ArH), 
7.31 (1H, br t, J= 8.8 Hz, ArH), 6.94 (1H, dd, J= 8.8, 3.2 
Hz, ArH), 6.87 (1H, br d, J= 10.5 Hz, ArH ), 6.84 (1H, br d, 
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J= 8.5 Hz, ArH), 6.82 (1H, br s, ArH), 3.82 (3H, s, OCH3), 
3.81 (3H, s, OCH3). 
13C NMR (CDCI3) 5C: 
55.3 (OCH3), 55.6 (OCH3), 107.4, 111.8, 112.2, 113.6, 
116.6, 119.3, 129.7, 131.7, 135.1, 151.4, 158.5, 160.4 (12 
ArC), 160.4 (C02). 
MS m/z 337.0072 
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Abstract 
From the aqueous extract of the dry rhizomes of Gunnera perpensa the minor components pyrogallol, succinic acid, lactic acid, 
and the trimethyl ether of ellagic acid glucoside were isolated. The major constituent was identified as Z-venusol, a phenylpropanoid 
glucoside. Its structure was verified by X-ray diffraction. Tests on isolated uterine smooth muscle from rats showed that the whole 
extract stimulated a direct contractile response and induced a state of continuous contractility of the uterus once all additives had 
been removed from the organ bath. By contrast, venusol did not trigger the direct contractile response but induced the state of 
continuous contractility once the organ bath was flushed. 
© 2004 Elsevier Ltd. All rights reserved. 
Keywords: Z-venusol; X-ray structure; Lespedezic acid; Uterine contraction; Expulsion of placenta; Spontaneous contractility 
1. Introduction 
Gunnera perpensa (Gunneraceae), known as river 
pumpkin, or "uGhobo" in isiZuhi, is a perennial shrub 
which grows along stream banks in many parts of South 
Africa. It is best known in the province of Kwa-Zulu 
Natal where it has been used traditionally as a "muthi" 
(medicinal) plant by the indigenous Zulu people for a 
long time. One of the first references to it in the Western 
literature is by the missionary Father J. Gerstner (1939). 
Traditionally the finely ground roots of the plant are 
boiled in water and administered orally to an animal 
(cow) after calving in order to expel the retained pla-
centa. The extract operates by inducing vigorous uterine 
contractions. Human uses of the aqueous decoction are 
relief of pain in rheumatic fever, to ensure an easy 
childbirth, and to treat infertility in women (Hutchings, 
1996). It is of interest to note that Dr. Tod Collins 
(1996) a western trained veterinarian from the Under-
berg district of KwaZulu-Natal, speaks highly of his 
Corresponding author. Tel.: + 33-260-5243; fax: +33-260-5009. 
E-mail address: drewes@nu.ac.za (S.E. Drewes). 
practical experiences with "uGhobo" and endorses the 
use of the plant by stock farmers. 
Some preliminary screening has been done on South 
African traditional remedies used during labour (Kaido 
et al. 1997). Masika and Afolayan (2002) have tested 
other indigenous plants as ethnoveterinary medicines. 
Despite its widespread use the chemical composition of 
Gunnera perpensa is not known. 
2. Results and discussion 
2.1. Isolation of components 
Gunnera perpensa roots were extracted with boiling 
water (as is done traditionally) and the dark red solu-
tion partitioned against ethyl acetate containing 
approximately 10% ethanol. Subsequent separation 
(flash column chromatography with methanol and 
chloroform) afforded small quantities of succinic acid, 
lactic acid, pyrogallol and the glucoside of ellagic acid 
trimethyl ether (1). It is known that ellagic acid is a 
potent antagonist, in particular on histamine liberators 
(Bhargava and Westfall, 1969). The activity of venusol 
0031-9422/$ - see front matter © 2004 Elsevier Ltd. All rights reserved, 
doi: 10.1016/j .phy tochem.2004.02.024 
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may well be modulated by the presence of the other 
compounds. 
The ethyl acetate extract of aq. Gunnera solution 
yielded buff needles of the compound venusol (0.18% 
yield based on dry plant material). Recrystallisation 
afforded orthorhombic needles, suitable for X-ray 
analysis. Information from this, coupled with the usual 
'H- and 13C-NMR and high resolution mass spectral 
data, enabled us to establish the structure unambigu-
ously as Z-venusol, (7,8-dihydroxy-6-(hydroxymethyl)-3 
- [(Z) - (4 - hydroxyphenyl)methylidene]tetrahydro - 4aH -
pyrano[2,3-b][l,4]dioxin-2-one (IUPAC nomenclature). 
The structure is shown in 2, but the usual numbering 
(Proliac et al. 1981) has been retained. 
Z-Venusol has been isolated previously by Proliac et 
al. (1981) and Pagani (1990). Both the Z and E isomers 
were obtained recently by Viornery et al. (2000). In all 
these instances the plant source was Umbilicus pendulinus 
or Umbilicus ruperstris (Crassulaceae). 
From molecular modeling experiments and NOE data 
Viornery et al. (2000) was able to distinguish between 
the Z- and ^-isomers of venusol. This designation of 
stereochemistry also confirmed the earlier work of 




O- p -D-glc 
C02Me 
(Z)-Methyl lespedezate (3) 
Me = H (Z)-Lespedezic acid (4) 
(3). The chemical relationship between venusol (2) and 
methyl lespedezate (3) is a close one. In the aq. Gunnera 
extract we found traces of (3) accompanying the major 
component venusol (2). This is likely to be an artefact 
resulting from the action of methanol (used in the 
extraction process) on the venusol. Shigemori et al. 
(1990) were able to show that potassium lespedezate 
and its geometrical isomer, potassium isolespedezate 
operate as an "internal clock" in the nyctinastic plant 
Cassia mimosoides and are involved in the leaf-opening 
and leaf-closing mechanisms. 
Recently Ohnuki et al. (1998) have considered the 
leaf-opening and leaf-closing mechanisms at the mole-
cular level as a result of their findings in nyctinastic 
plants. These authors were able to isolate both isomers 
of potassium lespedezate from Lespedeza cuneata (leaf-
openers). In addition they also isolated the leaf-closing 
substance potassium D-idarate (6). Their detailed stud-
ies indicate that leaf movement of nyctinastic plants is 
controlled by the competitive interaction between leaf-
opening [K-lespedezate, (E or Z isomer)] substances and 
leaf-closing [K-D-idarate (6)] substances. In the evening 
the enzyme P-glucosidase simply converts K-lespedezate 
to its deactivated form, potassium 4-hydroxy-
phenylpyruvate (7), i.e. the leaf-opening mechanism is 
"switched off' by enzymic deactivation of lespedezic 
acid. 
We believe that the above studies are relevant to our 
work on Gunnera as they illustrate the point that all 
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to be present for the system to function. In the 
nyctinastic plants all the interacting compounds are pre-
sent in the plant sap, just as they appear to be present in the 
crude Gunner a extracts. At present our investigations have 
only yielded one of the compounds involved and this may 
explain the type of activity observed (see Section 2.3). 
While venusol is not a new compound, it has now 
been isolated from a new plant source (family 
Gunneraceae). From our X-ray data of the compound 
the Z-stereochemistry around the C-2/C-3 double bond is 
established unambiguously. The final mechanism remains 
unclear, but there is good evidence that Z-venusol brings 
about contraction of uterine muscle (see below). 
2.2. Biological activity 
The effect of aq. Gunnera extract, ethyl acetate extract, 
ethyl acetate-methanol extract, and pure Z-venusol, 
were tested on uterine and ileal muscle obtained from 
Sprague-Dawley rats. The procedure has been described 
previously (Matonhodze et al., 2002). 
The aq. Gunnera extract directly stimulates a con-
tractile response for both the ileum and uterus muscle. 
Once the plant extract and the added acetylcholine are 
rinsed from the organ bath, the tissue enters into a state 
of continuous spontaneous contractility. Pre-incubation 
with atropine reduced the contractile response 
significantly. We speculate from the above that the 
muscarinic receptor system is involved in the direct 
contractile response to the whole plant extract. 
Neither the organic extracts nor the pure Z-venusol 
(2) elicited a direct contractile response. However, the 
venusol did induce a state of spontaneous contractility 
once the test substance was flushed from the organ 
bath. It is possible that the venusol exerts its action 
in conjunction with substances present in the whole 




'H and 13C NMR spectra were recorded on a Varian 
500 MHz NMR spectrometer. High resolution mass 
spectra were measured on a Kratos MS 80 RF double-
focussing magnetic sector instrument at 70 eV. The 
X-ray structure was obtained with an Oxford Xcalibur 2 
CCD diffractometer, (M„K„) radiation. 
3.2. Plant material 
Gunnera perpensa roots were collected in May 2002 on 
a farm in the Underberg district of Kwa-Zulu Natal and 
allowed to dry out in a shady place. A voucher specimen 
(leaves and root) was deposited in the Bews Herbarium, 
University of Natal, Pietermaritzburg (lodged under 
S.E. Drewes, N.U. 8). Verification of identity was done 
by Dr. Trevor Edwards, curator of the herbarium. 
3.3. Extraction and isolation 
The dry root material (910 g) was milled finely and 
extracted with boiling water (7 1) for 3 h. Preliminary 
tests had shown that even polar organic solvents, such 
as ethanol, dissolved almost none of the material. After 
filtration and autoclaving the red-brown solution was 
partitioned against ethyl acetate. This was a slow pro-
cess since an emulsion formed readily which necessi-
tated long periods of waiting between shaking. 
Emulsion-formation was largely inhibited by resorting 
to ethyl acetate-methanol (5:1) mixtures and this also 
resulted in more material being extracted. Concen-
tration of the ethyl acetate-methanol extract to about 2 
1, followed by drying (anhyd MgS04) and subsequent 
further concentration afforded a brown oil which crys-
tallized on standing (1.67 g, representing 0.18% yield 
Fig. 1. X-ray structure of (Z) venusol (2). 
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based on dry plant material). The crude crystalline 
material subsequently proved to be Z-venusol which 
was difficult to get absolutely pure. Final purifica-
tion required separation by flash chromatography 
and elution with methanol-chloroform (3:17). The 
white needles had mp 259 °C (Proliac et al., 1981, 
quote 259-260 °C) and proved to be suitable for X-ray 
analysis. 
Examination of a tic plate of the mother liquor of the 
Z-venusol [run in MeOH-CHCl3 (3:17)] and visualized 
with vanillin-H2S04 dip reagent revealed the presence 
of at least another seven compounds. Several of these 
were subsequently identified and proved to be very 
minor components of known structure. These com-
pounds were: RF 0.90, 4-0-P-D-glucopyranosyl-3,3',4'-
tri-O-methyl-ellagic acid (1); RF 0.81, Blue fluorescent 
compound (phytosterol); RF 0.76, Blue fluorescent 
compound; RF 0.60, No fluorescence, purple on heating 
with dip reagent—lactic acid, 15 mg; RF 0.54, Faint 
fluorescence, red with dip reagent—pyrogallol, char-
acterized as the triacetate, 37 mg; RF 0.41, Venusol— 
strongly fluorescent, buff coloured with dip reagent, 
1.67 g; RF 0.36, Weak fluorescence, green blue with dip 
reagent—(Z) methyl lespedezate, 10 mg; RF 0.16, 
Fluorescent—pale purple with dip reagent. 
Succinic acid mp 182 °C, in very low concentration 
was isolated from the mother liquor of venusol. It is not 
readily detected by tic. 
The ellagic acid derivative, 4-O-P-D-glucopyranosyl-
3,3',4'-tri-0-methylellagic acid (1) was present in low 
concentration but was readily identified by 'H and 13C 
NMR (Khac et al., 1990; Li et al. 1999) as well as by 
high-resolution mass spectrometry of its aglycone. 
H-R EI-MS m\z 344.05434 M + calc. for 
C,7H1208 = 344.05322. 
The methyl Z-lespedezate (3) was readily identified by 
comparison with the spectral data provided by Viornery 
et al. (2000). The NMR features which distiguish it from 
Z-venusol are the sharp methoxy peak at 8H 3.81 and at 
8C 52.6 (deuteriomethanol). In addition, the anomeric 
cabon resonates at 8C 102.8 whereas in venusol it is at 8C 
96.2. 
3.4. Z-venusol 
Fine white needles, mp 259 °C, [a£° = 84.5 (MeOH, 
0.245). 'H and l3C spectra run in D 2 0 and CD3OD 
were compared with those recorded by Proliac et al. 
(1981) in DMSO and by Viornery et al. (2000) 
in C2D6CO, and leave no doubt about the identity of 
the compound. Its stereochemistry about the C-2/C-3 
double bond was unambiguously proved to be Z by 
X-ray diffraction (see below) (Fig. 1). 
Acetylation of Z-venusol afforded an oil, [a]p=25 
(MeOH, 0.028). 'H NMR (500 MHz, CDC13): 8 2.05, 
2.09, 2.12 (9H, 5, 3', 4', 6'-OAc), 2.30 (3H, .?, 7-0Ac), 
Table 1 
X-ray data for Z-venusol (2) 






Unit cell dimensions 
6 = 9.2990(16) A, ^ = 90° 





Theta range for data collection 
Reflections collected 
Independent reflections 
Completeness to theta = 25.00° 
Absorption correction 
Refinement method 
Goodness of fit on F2 
Final R indices [I > 2 sigma (/)] 
R indices (all data) 
Absolute structure parameter 
324.28 











4251 [/?(int) = 0.0335] 
99.1% 
None 
Full-matrix least squares on F2 
1.009 
Rl =0.0364, w#2 = 0.0814 
R\ =0.0455, w/?2 = 0.0850 
-0.7 (7) 
The complete set of data (atomic coordinates, equivalent isotropic 
displacement parameters, bond lengths and bond angles, anisotropic 
displacement parameters, hydrogen coordinates and torsion angles) 
will be lodged with the Cambridge Crystallographic center. 
3.95 (1H, ddd, 7 10.1, 4.4, 2.2, H-5'), 4.21 (1H, dd, 
7=12.7, 2.2, H-6'a), 4.32 (1H, dd, J 12.8, 4.4, H-6'b), 
4.32 (1H, dd, 7 9.9, 7.9, H-2'), 5.09 (1H, d, J'=7.9, H-l'), 
5.13 (1H, dd, 7 10.1, 9.2, H-4'), 5.39 (1H, dd, 7 9.9, 9.2, 
H-3'), 6.98 (1H, s, H-3), 7.12 (2H, d, 7=8.7, H-5/9), 
7.77 (2H, d, 7=8.7, H-6/8); 13C NMR (125 MHz, 
CDC13): 8 20.5, 20.6, 20.7 (C-3', 4', 6'-OAc), 21.1 (C-7-
OAc), 61.3 (C-6'), 67.8 (C-4'), 70.9 (C-3'), 73.6 (C-5'), 
75.6 (C-2'), 94.6 (C-l'), 120.3 (C-3), 121.9 (C-6/8), 130.0 
(C-4), 132.1 (C-5/9), 136.2 (C-2), 151.3 (C-7), 159.0 (C-
1), 169.1, 169.4, 169.7 (C-3', 4', 6'-OAc), 170.5 (C-7-
OAc); H-R EIMS m/z 492.126648. M + calc for 
C23H24012 = 492.126777. EI-MS m/z (rel. int.): 492 
(M + ) (77), 450 (10), 408 (3), 289 (22), 194 (48), 176 (88), 
169 (100), 163 (20), 134 (60), 127 (35), 109 (95), 43 
(58). 
3.5. X-ray crystrallography 
The X-ray data is collected in Table 1. 
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A triazine derivative with a triple-decker 
sandwich conformation 
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Key indicators 
Single-crystal X-ray study 
T = 295 K 
Mean IT(C-C) = 0.005 A 
R factor = 0.066 
wR factor = 0.224 
Data-to-parameter ratio =16.1 
For details of how these key indicators were 
automatically derived from the article, see 
http://journals.iucr.Org/e. 
1 In dimethyl 6,6'-bis(benzyloxy)-5,5'-dimethoxy)-3,3'-(6-meth-
2 oxy-l,3,5-triazine-2,4-diyldioxy)dibenzoate, C36H33N30U, a 
3 new triazine derivative, the benzyloxy groups adopt an 
4 interesting conformation in which they are positioned above 
5 and below the triazine ring 'core' of the molecule to form an 
6 intramolecular triple-decker sandwich. The ester carbonyl O 
7 atoms of adjacent molecules in the crystal structure participate 
8 in non-conventional (alkyl)C—H- • -O hydrogen bonds [aver-
9 aging 2.45 (1)A] about an inversion centre to give a weakly 
10 hydrogen-bonded dimer. 
11 Comment 
12 A new triazine derivative (I) was isolated in crystalline form 
13 after work-up of the reaction of 2,4-dichloro-6-methoxy-l,3,5-
14 triazine and methyl 4-benzyloxy-3-hydroxy-5-methoxy-
15 benzoate in the presence of 7V-methylmorpholine (NMM) 
16 using conditions described in the literature (Kunishima et al, 
17 1999). The structure of (I) is of general interest since phen-
18 oxytriazine derivatives have recently been shown to form 
19 intriguing supramolecular structures when a suitable 
20 hydrogen-bonding substituent is present on the phenoxy ring 
21 (Aakeroy et al, 2005; Lebel et al, 2006; Suss et al, 2005). 
22 
Received 30 November 2006 
Accepted 12 December 2006 
H,C. 
23 The triazine ring core of (I) is sandwiched between the two 
24 phenyl rings of the benzyloxy groups (Figs. 1 and 2). The 
25 dihedral angles between the top (C11-C15) and bottom (C36-
26 C33) phenyl rings and the triazine ring are 10.9 (2) and 
27 12.9 (2)°, respectively. The distance between the centroid of 
28 the C11-C15 ring and the triazine ring is 3.58 (1) A, while that 
29 between the C33-C36 ring is somewhat longer at 3.85 (1) A. 
30 Although the intramolecular ring' • ring separations in (I) 
31 exceed the graphite spacing (3.35 A) and the rings are canted, 
© 2006 international Union of Crystallography 32 the possibility that the triple-decker sandwich conformation of 
All rights reserved 33 (I) is brought about by K- • -71 interactions cannot be excluded, 
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The molecular structure of (I) (45% probability displacement ellipsoids 
for all non-H atoms). 
Figure 2 
Space-filling plot (van der Waals radii) for (I), viewed approximately 
down the 06—C18 bond, illustrating the triple-decker sandwich 
arrangement of the phenyl and central triazine ring systems. 
34 particularly since intramolecular interactions of this type and 
35 magnitude have been described previously (Hunter et al, 
36 2001; Munro et al, 2003). Bond distances and angles are 
37 normal and warrant no further discussion. 
38 The anisotropic displacement parameters for the C atoms of 
39 both benzylic phenyl rings reflect libration of these groups in 
40 the room-temperature X-ray structure. Collection of the X-ray 
41 data at 100 (2) K to remedy this situation, however, afforded a 
42 data set of poorer quality (Rint = 0.055) due to partial frac-
43 turing of the crystal below 200 K. 
44 The unit-cell contents of (I) comprise the expected pair of 
45 molecules situated about the inversion centre and located at 
46 general positions in the triclinic unit cell. More interesting is 
47 the observation that molecules of (I) associate by weak non-
48 conventional hydrogen bonds (Table 1) to form a centro-
49 symmetric hydrogen-bonded dimer (Fig. 3). The C-H donors 
50 in these nominally weak (Steiner, 2002) C—H- • -O(carbonyl) 
51 interactions are not particularly acidic, yet the contact 
52 distances are shorter than the sum of the van der Waals radii 
53 of oxygen and hydrogen (2.72 A) by more than 0.25 A. This 
54 fact suggests that the interactions listed in Table 1 are more 
55 than simple non-bonded contacts in the case of (I). 
0 2 Peter e t a / . • C 3 6 H 3 3 N 3 O n 
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Figure 3 
Hydrogen-bonded dimer with inversion symmetry. Atoms involved in the 
interaction have been labelled. Hydrogen bonds are shown as dashed 
lines. All other H atoms have been omitted for clarity. [Symmetry code: 
(i) -x, 2-y, -z] 
56 Experimental 
57 A mixture of 100 ml of methanol, 13.5 ml of water and 16.5 g 
58 (0.2 mol) of sodium bicarbonate was cooled to 283-288 K. Cyanuric 
59 chloride (18.4 g, 0.1 mol) was added and the resulting mixture was 
60 warmed to 308 K then stirred at 308 K for 20 min and at room 
61 temperature for 30 min. Water was added to the reaction mixture and 
62 the precipitated product filtered under vacuum, washed with water 
63 and dried under vacuum to yield 2,4-dichloro-6-methoxy-l,3,5-tria-
64 zine as a white solid (5.2 g, 28% yield). A solution of 2,4-dichloro-6-
65 methoxy-l,3,5-triazine (72 mg, 0.40 mmol) and methyl 4-benzyloxy-3-
66 hydroxy-5-methoxybenzoate (58 mg, 0.20 mmol) in THF (20 ml) was 
67 stirred under nitrogen. TV-Methylmorpholine (24 mg, 0.24 mmol) was 
68 added and, after stirring for 4 h, the reaction mixture was poured into 
69 water and extracted with ethyl acetate. The organic phase was washed 
70 successively with a saturated NaHC03 solution, water, 1 N HCl, 
71 water and brine and dried over MgS04. The crude product was 
72 purified by column chromatography on Si02 (hexane-ethyl acetate = 
73 7:3) to afford compound (I) as a cream-white solid (92 mg, 67%). 
74 Recrystallisation by slow evaporation of a methanol solution of (I) 
75 gave the compound as colourless crystals (m.p. 371-373 K). Atom 
76 numbering consistent with the crystallographic labelling scheme of 
77 Fig. 1 applies to the following characterization data where necessary. 
78 'HNMR (500MHz,CDC13): SH7.51 (2H,d,J=\9 Hz,H4/H24),7.43 
79 (2H, d, J = 1.9 Hz, H2/H22), 7.23-7.25 (10H, m, Ar-H), 5.06 (4H, s, -
80 CH2-), 3.92 (6H, s, COOMe), 3.90 (6H, s, C9-OMe/C29-OMe), 3.77 
81 (3H, s, C206-OMe). ,3C NMR (125 MHz, CDC13) Sc 173.6 (C17/C19), 
82 173.0 (C18), 165.9 (C=0), 153.3 (C5/C25), 144.7 (C6/C26), 144.0 (C3/ 
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83 C23) 136.9 (C11/C31), 128.2 (m-C, phenyl) , 127.8 (p-C, phenyl) , 127.< 
84 (o-C, phenyl) , 125.2 (C1/C21), 116.8 (C2/C22), 111.2 (C4/C24), 74.f 
85 (C10/C30), 56.2 (C9/C29), 55.4 (C20), 52.2 (C8/C28). 
Crystal data 
C36H33N3On 
M, = 683.65 
Triclinic, P\ 
a = 8.5540 (7) A 
b = 11.1363 (8) A 
c = 17.9894 (13) A 
a = 92.746 (6)° 
P = 94.278 (6)° 
y = 96.246 (6)° 
Data collection 
Oxford Diffraction Xcalibur 2 CCD 
diffractometer 
to scans 
Absorption correction: none 
13313 measured reflections 
Refinement 
Refinement on F2 
R{F2 > 2a(F2)] = 0.066 
wR(F2) = 0.224 
S = 1.06 
7354 reflections 
456 parameters 
H-atom parameters constrained 
Table 1 
Hydrogen-bond geometry (A, °). 
V = 1696.0 (2) A3 
Z = 2 
Dx = 1.339 Mg irT
3 
Mo Kct radiation 
p. = 0.1 m m - 1 
T = 295 (2) K 
Rhomb, colourless 
0.6 x 0.4 x 0.25 mm 
7354 independent reflections 
4422 reflections with / > 2a(T) 
Rmx = 0.024 
0m a . = 27.1" 
w = \l[a2(F2) + (0.1153P)2 
+ 0.3795P] 
where P = (Fa
2 + 2F2)B 
(A/<r)maI = 0.001 
Ap™, = 0.29 e A7* 
Apmin = -0.19 e A
- 3 












Symmetry code: (i) — x, —y -f 2. — z. 
89 = 0.96A and f/ i so(H) = 1.5C/eq(C). Methy lene H a toms were placed 
90 geometrically and refined using a riding model , with C — H = 0.97A 
91 and f/;so(H) = 1.2t/c q(C). Aromat i c H a toms were placed geome-
92 trically and refined using a riding model , with C — H = 0.93A and 
93 t / i s o (H) = 1.2£/cq(C). 
94 Da ta collection: CrysAlis CCD (Oxford Diffraction, 2004); cell 
95 refinement: CrysAlis RED (Oxford Diffraction, 2004); data reduc-
96 tion: CrysAlis RED; p rogram(s) used to solve s t ruc ture : SHELXS97 
97 (Sheldrick, 1997); program(s) used to refine s t ruc ture : SHELXL97 
98 (Sheldrick, 1997); molecular graphics: ORTEP-3 (Farrugia, 1997); 
99 software used to p r epa re mater ial for publicat ion: WinGX (Farrugia, 
100 1999). 
101 
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87 Methyl H a toms were placed geometrically and refined as rigid 125 
88 rota t ing groups (torsion angles from the electron density), with C—H 126 
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83 C23) 136.9 (C11/C31), 128.2 (m-C, phenyl ) , 127.8 (p-C, phenyl) , 127.( 
84 (o-C, phenyl ) , 125.2 (C1/C21), 116.8 (C2/C22), 111.2 (C4/C24), 74.i 
85 (C10/C30), 56.2 (C9/C29), 55.4 (C20), 52.2 (C8/C28). 
Crystal data 
C36H33N3On 
M, = 683.65 
Triclinic, P\ 
a = 8.5540 (7) A 
b = 11.1363 (8) A 
c = 17.9894 (13) A 
a = 92.746 (6)° 
fi = 94.278 (6)° 
y = 96.246 (6)° 
Data collection 
Oxford Diffraction Xcalibur 2 CCD 
diffractometer 
a> scans 
Absorption correction: none 
13313 measured reflections 
Refinement 
Refinement on F 2 
R{F2 > 2<r(F2)] = 0.066 
wR(F2) = 0.224 
5 = 1.06 
7354 reflections 
456 parameters 
H-atom parameters constrained 
Table 1 
Hydrogen-bond geometry (A, °). 
V = 1696.0 (2) A3 
Z = 2 
D, = 1.339 Mg m~3 
Mo Ka radiation 
H = 0.1 m m - 1 
T = 295 (2) K 
Rhomb, colourless 
0.6 x 0.4 x 0.25 mm 
7354 independent reflections 
4422 reflections with / > 2a(T) 
R,M = 0.024 
#ma* = 27.1" 
w = l/[ff2(F„2) + (0.1153P)2 
+ 0.3795/'] 
where P = (Fa
2 + 2Fc
2)/3 
(A/o-)max = 0.001 
A p m „ = 0.29 e A"
3 
&pmin = -0.19 e A"
3 













Symmetry code: (i) — x, —y + 2, 
I 89 = 0.96A and £/ist>(H) = 1.5I/ e q(C). Methy lene H a t o m s were placed 
! 90 geometrically and refined using a riding model , with C—H = 0.97A 
91 and £/ i so(H) = 1.2[/e<1(C). Aromat i c H a toms w e r e placed geome-
92 trically and refined using a riding model , with C — H = 0.93A and 
93 c/ i so(H) = 1.2£/eq(C). 
94 D a t a collection: CrysAlis CCD (Oxford Diffraction, 2004); cell 
95 refinement: CrysAlis RED (Oxford Diffraction, 2004); da ta reduc-
96 t ion: CrysAlis RED; p rogram(s) used t o solve s t ruc ture : SHELXS97 
97 (Sheldrick, 1997); program(s) used t o refine s t ruc ture : SHELXL97 
98 (Sheldrick, 1997); molecular graphics: ORTEP-3 (Farrugia, 1997); 
99 software used to p r epa re mater ial for publicat ion: WinGX (Farrugia, 
100 1999). 
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